0000797542 2026-01-01 2026-06-30 0000797542 2026-08-13 0000797542 2026-06-30 0000797542 2025-12-31 0000797542 2025-01-01 2025-06-30 0000797542 2026-04-01 2026-06-30 0000797542 2025-04-01 2025-06-30 0000797542 us-gaap:CommonStockMember 2025-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000797542 us-gaap:RetainedEarningsMember 2025-12-31 0000797542 us-gaap:ParentMember 2025-12-31 0000797542 us-gaap:NoncontrollingInterestMember 2025-12-31 0000797542 us-gaap:CommonStockMember 2026-03-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000797542 us-gaap:RetainedEarningsMember 2026-03-31 0000797542 us-gaap:ParentMember 2026-03-31 0000797542 us-gaap:NoncontrollingInterestMember 2026-03-31 0000797542 2026-03-31 0000797542 us-gaap:CommonStockMember 2024-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000797542 us-gaap:RetainedEarningsMember 2024-12-31 0000797542 us-gaap:ParentMember 2024-12-31 0000797542 us-gaap:NoncontrollingInterestMember 2024-12-31 0000797542 2024-12-31 0000797542 us-gaap:CommonStockMember 2025-03-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000797542 us-gaap:RetainedEarningsMember 2025-03-31 0000797542 us-gaap:ParentMember 2025-03-31 0000797542 us-gaap:NoncontrollingInterestMember 2025-03-31 0000797542 2025-03-31 0000797542 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0000797542 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0000797542 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0000797542 us-gaap:ParentMember 2026-01-01 2026-06-30 0000797542 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-06-30 0000797542 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000797542 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000797542 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000797542 us-gaap:ParentMember 2026-04-01 2026-06-30 0000797542 us-gaap:NoncontrollingInterestMember 2026-04-01 2026-06-30 0000797542 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0000797542 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0000797542 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0000797542 us-gaap:ParentMember 2025-01-01 2025-06-30 0000797542 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-06-30 0000797542 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000797542 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000797542 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000797542 us-gaap:ParentMember 2025-04-01 2025-06-30 0000797542 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0000797542 us-gaap:CommonStockMember 2026-06-30 0000797542 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000797542 us-gaap:RetainedEarningsMember 2026-06-30 0000797542 us-gaap:ParentMember 2026-06-30 0000797542 us-gaap:NoncontrollingInterestMember 2026-06-30 0000797542 us-gaap:CommonStockMember 2025-06-30 0000797542 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000797542 us-gaap:RetainedEarningsMember 2025-06-30 0000797542 us-gaap:ParentMember 2025-06-30 0000797542 us-gaap:NoncontrollingInterestMember 2025-06-30 0000797542 2025-06-30 0000797542 2026-03-04 0000797542 QXL:CliniQuantumMember 2026-06-04 0000797542 QXL:VirtualCryptoTechnologiesLtdIsraelMember 2020-01-27 2020-01-27 0000797542 QXL:GixInternetLtdMember QXL:ShareExchangeAgreementMember 2019-02-07 0000797542 QXL:GixMediaLtdMember 2021-12-05 0000797542 2022-09-19 0000797542 2022-09-19 2022-09-19 0000797542 2022-08-31 2022-08-31 0000797542 QXL:SecuritiesExchangeAgreementMember 2025-03-24 0000797542 QXL:SecuritiesExchangeAgreementMember 2025-03-24 2025-03-24 0000797542 us-gaap:CommonStockMember QXL:SecuritiesExchangeAgreementMember 2025-03-24 2025-03-24 0000797542 srt:MaximumMember QXL:SecuritiesExchangeAgreementMember 2025-03-24 2025-03-24 0000797542 QXL:SecuritiesExchangeAgreementMember 2026-03-04 0000797542 QXL:PrefundedWarrantsMember QXL:SecuritiesExchangeAgreementMember 2026-03-04 2026-03-04 0000797542 QXL:GixMediaLtdMember 2025-03-27 2025-03-27 0000797542 QXL:GixMediaLtdMember 2025-07-22 2025-07-22 0000797542 2025-06-01 2025-07-31 0000797542 2025-07-14 2025-07-14 0000797542 2026-03-04 2026-03-04 0000797542 2026-06-01 2026-06-30 0000797542 us-gaap:SubsequentEventMember 2026-07-01 2026-07-31 0000797542 2025-04-10 0000797542 2025-07-20 2025-07-20 0000797542 us-gaap:InProcessResearchAndDevelopmentMember 2025-12-31 0000797542 QXL:InternalSoftwareMember 2025-12-31 0000797542 QXL:CustomerRelationsMember 2025-12-31 0000797542 QXL:TechnologyMember 2025-12-31 0000797542 us-gaap:GoodwillMember 2025-12-31 0000797542 us-gaap:InProcessResearchAndDevelopmentMember 2026-01-01 2026-06-30 0000797542 QXL:InternalSoftwareMember 2026-01-01 2026-06-30 0000797542 QXL:CustomerRelationsMember 2026-01-01 2026-06-30 0000797542 QXL:TechnologyMember 2026-01-01 2026-06-30 0000797542 us-gaap:GoodwillMember 2026-01-01 2026-06-30 0000797542 us-gaap:InProcessResearchAndDevelopmentMember 2026-06-30 0000797542 QXL:InternalSoftwareMember 2026-06-30 0000797542 QXL:CustomerRelationsMember 2026-06-30 0000797542 QXL:TechnologyMember 2026-06-30 0000797542 us-gaap:GoodwillMember 2026-06-30 0000797542 QXL:InternalSoftwareMember 2024-12-31 0000797542 QXL:CustomerRelationsMember 2024-12-31 0000797542 QXL:TechnologyMember 2024-12-31 0000797542 us-gaap:GoodwillMember 2024-12-31 0000797542 QXL:InternalSoftwareMember 2025-01-01 2025-12-31 0000797542 QXL:CustomerRelationsMember 2025-01-01 2025-12-31 0000797542 QXL:TechnologyMember 2025-01-01 2025-12-31 0000797542 us-gaap:GoodwillMember 2025-01-01 2025-12-31 0000797542 2025-01-01 2025-12-31 0000797542 QXL:CortexAcquisitionMember 2021-10-13 2021-10-13 0000797542 2021-10-13 0000797542 QXL:GixMediaMember 2021-10-13 0000797542 QXL:GixMediaLtdMember 2023-01-23 0000797542 QXL:CortexAcquisitionMember 2023-01-23 0000797542 QXL:GixMediaMember 2023-01-23 2023-01-23 0000797542 QXL:GixMediaLtdMember QXL:SharePurchaseAgreementMember 2025-11-09 2025-11-09 0000797542 QXL:GixMediaLtdMember QXL:SharePurchaseAgreementMember 2025-11-09 0000797542 QXL:GixMediaLtdMember QXL:SeriesJPreferredStockMember QXL:SharePurchaseAgreementMember 2025-11-09 2025-11-09 0000797542 QXL:MetagrammSoftwareLtdMember 2025-03-24 2025-03-24 0000797542 QXL:MetagrammSoftwareLtdMember QXL:TechnologyMember 2025-03-24 0000797542 QXL:MetagrammSoftwareLtdMember QXL:CustomerRelationsMember 2025-03-24 0000797542 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember QXL:SecuritiesExchangeAgreementMember 2025-12-15 2025-12-15 0000797542 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember QXL:SecuritiesExchangeAgreementMember 2025-11-01 2025-11-30 0000797542 QXL:PrefundedWarrantsMember us-gaap:PrivatePlacementMember QXL:SecuritiesExchangeAgreementMember 2025-11-30 0000797542 QXL:PrefundedWarrantsMember us-gaap:PrivatePlacementMember QXL:SecuritiesExchangeAgreementMember 2025-11-01 2025-11-30 0000797542 srt:MaximumMember us-gaap:CommonStockMember QXL:SecuritiesExchangeAgreementMember 2025-12-15 2025-12-15 0000797542 srt:MinimumMember us-gaap:CommonStockMember QXL:SecuritiesExchangeAgreementMember 2025-12-15 2025-12-15 0000797542 QXL:SecuritiesExchangeAgreementMember 2025-12-15 2025-12-15 0000797542 QXL:QuantumXLabsLtdMember 2026-03-04 2026-03-04 0000797542 QXL:QuantumXLabsLtdMember us-gaap:CommonStockMember 2026-03-04 2026-03-04 0000797542 QXL:QuantumXLabsLtdMember us-gaap:WarrantMember 2026-03-04 0000797542 QXL:FinancingAgreementMember 2026-03-04 0000797542 QXL:CliniQuantumLtdMember 2026-06-03 0000797542 QXL:CliniQuantumLtdMember 2026-06-03 2026-06-03 0000797542 QXL:MetagrammSoftwareLtdMember 2026-01-01 2026-06-30 0000797542 QXL:QuantumIsraelMember 2026-01-01 2026-06-30 0000797542 QXL:MetagrammSoftwareLtdMember 2025-03-24 0000797542 QXL:QuantumIsraelMember 2025-03-04 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdMember 2026-06-30 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdMember 2025-12-31 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdMember 2026-01-01 2026-06-30 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdMember 2025-01-01 2025-12-31 0000797542 QXL:JulyTenTwoThousandTwentyFiveMember QXL:GixMediaLtdMember 2026-06-30 0000797542 QXL:JulyTenTwoThousandTwentyFiveMember QXL:GixMediaLtdMember 2025-12-31 0000797542 QXL:JulyTenTwoThousandTwentyFiveMember QXL:GixMediaLtdMember 2026-01-01 2026-06-30 0000797542 QXL:JulyTenTwoThousandTwentyFiveMember QXL:GixMediaLtdMember 2025-01-01 2025-12-31 0000797542 QXL:ConvertibleLoanJuneFacilityMember QXL:QuantumXLabsIncMember 2026-06-30 0000797542 QXL:ConvertibleLoanJuneFacilityMember QXL:QuantumXLabsIncMember 2025-12-31 0000797542 QXL:QuantumXLabsIncMember 2026-06-30 0000797542 QXL:QuantumXLabsIncMember 2025-12-31 0000797542 QXL:FinancingAgreementMember QXL:GixMediaMember 2021-10-13 0000797542 us-gaap:LineOfCreditMember QXL:FinancingAgreementMember QXL:GixMediaMember 2021-10-13 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdOneMember 2025-06-18 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdOneMember 2025-06-18 2025-06-18 0000797542 QXL:GixMediaLtdOneMember 2025-06-18 2025-06-18 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdOneMember 2025-07-03 0000797542 QXL:ShortTermBankLoanMember QXL:GixMediaLtdOneMember 2025-07-03 2025-07-03 0000797542 QXL:GixMediaLtdOneMember 2025-07-03 2025-07-03 0000797542 QXL:FinancingAgreementMember QXL:GixMediaAndLeumiMember 2025-07-08 0000797542 QXL:FinancingAgreementMember QXL:GixMediaAndLeumiMember 2025-07-08 2025-07-08 0000797542 QXL:JulyTwoThousandTwentyFiveRepaymentAndFinancingAgreementMember QXL:GixMediaLtdMember 2025-07-01 2025-07-31 0000797542 QXL:JulyTwoThousandTwentyFiveRepaymentAndFinancingAgreementMember QXL:GixMediaLtdMember 2025-07-31 0000797542 QXL:GixMediaLtdMember 2025-07-01 2025-07-31 0000797542 QXL:ViewbixIsraelMember QXL:LoanAgreementMember 2023-11-15 0000797542 QXL:ViewbixIsraelMember QXL:TwoThousandTwentyThreeWarrantMember 2023-11-15 0000797542 srt:MaximumMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 0000797542 QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 2024-06-18 0000797542 QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 2024-06-18 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 0000797542 QXL:JuneTwentyTwentyFourConvertibleStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 2024-06-18 0000797542 QXL:JuneTwentyTwentyFourConvertibleStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 0000797542 srt:MaximumMember QXL:JuneTwentyTwentyFourConvertibleStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2024-06-18 2024-06-18 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2024-06-18 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2024-06-18 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember 2024-07-31 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember 2024-06-18 2024-06-18 0000797542 QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-05 0000797542 QXL:JuneTwentyTwentyFourConvertibleStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-05 0000797542 srt:MaximumMember QXL:JuneTwentyTwentyFourConvertibleStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-05 2025-06-05 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-05 0000797542 QXL:JuneTwentyTwentyFourConvertibleStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-05 2025-06-05 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-07-01 2025-07-31 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-07-01 2025-07-31 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2026-06-01 2026-06-30 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2026-06-01 2026-06-30 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2026-04-01 2026-04-30 0000797542 us-gaap:SubsequentEventMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2026-07-31 0000797542 us-gaap:SubsequentEventMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2026-07-31 2026-07-31 0000797542 QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 0000797542 QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 2024-07-04 0000797542 us-gaap:CommonStockMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 2024-07-04 0000797542 us-gaap:CommonStockMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 0000797542 QXL:FirstJulyTwentyTwentyFourConvertibleStockMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 0000797542 QXL:FirstJulyTwentyTwentyFourLendersMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 2024-07-04 0000797542 QXL:FirstJulyTwentyTwentyFourLendersMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 0000797542 QXL:FirstJulyTwentyTwentyFourLendersMember us-gaap:CommonStockMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 2024-07-04 0000797542 QXL:FirstJulyTwentyTwentyFourLendersMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-31 0000797542 QXL:FirstJulyTwentyTwentyFourLendersMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-12-31 0000797542 us-gaap:WarrantMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2024-07-04 2024-07-04 0000797542 us-gaap:WarrantMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 us-gaap:CommonStockMember QXL:FirstJulyTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 0000797542 QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 2024-07-28 0000797542 us-gaap:CommonStockMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 2024-07-28 0000797542 us-gaap:CommonStockMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 0000797542 QXL:SecondJulyTwentyTwentyFourConvertibleStockMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 0000797542 QXL:SecondJulyTwentyTwentyFourLendersMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 2024-07-28 0000797542 QXL:SecondJulyTwentyTwentyFourLendersMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 0000797542 QXL:SecondJulyTwentyTwentyFourLendersMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-12-31 0000797542 us-gaap:WarrantMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2024-07-28 2024-07-28 0000797542 us-gaap:WarrantMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 us-gaap:CommonStockMember QXL:SecondJulyTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 QXL:EarnoutLiabilityMember 2025-12-31 0000797542 QXL:EarnoutLiabilityMember 2026-01-01 2026-06-30 0000797542 QXL:EarnoutLiabilityMember 2026-06-30 0000797542 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2024-12-31 0000797542 QXL:EarnoutLiabilityMember 2024-12-31 0000797542 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-01-01 2025-12-31 0000797542 QXL:EarnoutLiabilityMember 2025-01-01 2025-12-31 0000797542 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-12-31 0000797542 QXL:GixMediaLtdMember 2026-06-30 0000797542 QXL:QuantumIsraelMember 2026-06-30 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementMember 2025-06-05 2025-06-05 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementMember 2025-06-05 0000797542 us-gaap:WarrantMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-07-31 0000797542 us-gaap:CommonStockMember QXL:JuneTwentyTwentyFourFacilityAgreementMember 2025-06-01 2025-07-31 0000797542 QXL:FirstJulyTwoThousandTwentyFourFacilityAgreementMember 2025-06-05 2025-06-05 0000797542 QXL:FirstJulyTwoThousandTwentyFourFacilityAgreementMember 2025-06-05 0000797542 QXL:FirstJulyTwoThousandTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 QXL:SecondJulyTwoThousandTwentyFourFacilityAgreementMember 2025-06-05 2025-06-05 0000797542 QXL:SecondJulyTwoThousandTwentyFourFacilityAgreementMember 2025-06-05 0000797542 QXL:SecondJulyTwoThousandTwentyFourFacilityAgreementMember 2025-06-01 2025-06-30 0000797542 QXL:ConsultantMember 2025-06-15 2025-06-15 0000797542 QXL:ConsultantMember 2025-01-01 2025-12-31 0000797542 QXL:JuneTwentyTwentyFourFacilityAgreementMember 2026-06-30 0000797542 us-gaap:PrivatePlacementMember 2024-07-03 2024-07-03 0000797542 us-gaap:PrivatePlacementMember 2024-07-03 0000797542 QXL:PIPEWarrantsMember 2024-07-03 0000797542 us-gaap:InvestorMember us-gaap:PrivatePlacementMember 2024-07-03 2024-07-03 0000797542 us-gaap:InvestorMember us-gaap:PrivatePlacementMember 2024-07-03 0000797542 us-gaap:PrivatePlacementMember 2025-07-01 2025-07-31 0000797542 us-gaap:CommonStockMember 2025-07-01 2025-07-31 0000797542 us-gaap:WarrantMember 2025-07-01 2025-07-31 0000797542 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2025-07-11 2025-07-11 0000797542 QXL:PrefundedWarrantsMember us-gaap:PrivatePlacementMember 2025-07-11 0000797542 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-07-11 0000797542 us-gaap:PrivatePlacementMember 2025-07-11 2025-07-11 0000797542 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2025-07-14 2025-07-14 0000797542 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2024-07-14 2024-07-14 0000797542 2025-09-05 2025-09-05 0000797542 us-gaap:WarrantMember QXL:JulyTwentyTwentyFivePrivatePlacementMember 2026-06-01 2026-06-30 0000797542 us-gaap:CommonStockMember QXL:JulyTwentyTwentyFivePrivatePlacementMember 2026-06-01 2026-06-30 0000797542 us-gaap:CommonStockMember QXL:SecuritiesPurchaseAgreementMember 2026-01-01 2026-01-01 0000797542 us-gaap:WarrantMember QXL:SecuritiesPurchaseAgreementMember 2026-01-01 0000797542 us-gaap:CommonStockMember QXL:SecuritiesPurchaseAgreementMember 2026-01-01 0000797542 QXL:SecuritiesPurchaseAgreementMember 2026-01-01 2026-01-01 0000797542 QXL:SecuritiesPurchaseAgreementMember 2026-01-01 0000797542 QXL:JuneTwentyTwentyFourFacilityAgreementMember 2026-01-01 2026-01-01 0000797542 QXL:TwoThousandTwentySixPrivatePlacementMember 2026-03-04 2026-03-04 0000797542 QXL:TwoThousandTwentySixPrivatePlacementMember 2026-03-04 0000797542 QXL:TwoThousandTwentySixPrivatePlacementMember 2026-06-30 0000797542 us-gaap:WarrantMember QXL:TwoThousandTwentySixPrivatePlacementMember 2026-06-01 2026-06-30 0000797542 us-gaap:CommonStockMember QXL:TwoThousandTwentySixPrivatePlacementMember 2026-06-01 2026-06-30 0000797542 QXL:QuantumXLabsLtdMember 2026-06-01 2026-06-30 0000797542 QXL:QuantumXLabsLtdMember us-gaap:CommonStockMember 2026-06-01 2026-06-30 0000797542 2024-07-15 2024-07-15 0000797542 QXL:TwoThousandAndTwentyThreeStockIncentivePlanMember 2023-03-02 0000797542 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2025-07-11 0000797542 QXL:ClassJWarrantsMember 2026-06-30 0000797542 QXL:ClassJWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:ClassKWarrantsMember 2026-06-30 0000797542 QXL:ClassKWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember 2026-06-30 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember 2026-06-30 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentyFourPIPEWarrantsMember 2026-06-30 0000797542 QXL:TwentyTwentyFourPIPEWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember 2026-06-30 0000797542 QXL:TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:QuantumIsraelAcquisitionPreFundedWarrantsMember 2026-06-30 0000797542 QXL:QuantumIsraelAcquisitionPreFundedWarrantsMember 2026-01-01 2026-06-30 0000797542 QXL:ClassJWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:ClassJWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:ClassJWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:ClassKWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:ClassKWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:ClassKWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:JuneTwentyTwentyFourLeadLenderWarrantMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:TwentyTwentyFourPIPEWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:TwentyTwentyFourPIPEWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentyFourPIPEWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 QXL:QuantumIsraelAcquisitionPreFundedWarrantsMember us-gaap:WarrantMember 2025-12-31 0000797542 QXL:QuantumIsraelAcquisitionPreFundedWarrantsMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 QXL:QuantumIsraelAcquisitionPreFundedWarrantsMember us-gaap:WarrantMember 2026-06-30 0000797542 us-gaap:WarrantMember 2025-12-31 0000797542 us-gaap:WarrantMember 2026-01-01 2026-06-30 0000797542 us-gaap:WarrantMember 2026-06-30 0000797542 QXL:SearchSegmentMember 2026-01-01 2026-06-30 0000797542 QXL:QuantumTechnologySegmentMember 2026-01-01 2026-06-30 0000797542 QXL:AdjustmentsAndEliminationsMember 2026-01-01 2026-06-30 0000797542 QXL:SearchSegmentMember 2025-01-01 2025-06-30 0000797542 QXL:AdjustmentsAndEliminationsMember 2025-01-01 2025-06-30 0000797542 QXL:SearchSegmentMember 2026-04-01 2026-06-30 0000797542 QXL:QuantumTechnologySegmentMember 2026-04-01 2026-06-30 0000797542 QXL:AdjustmentsAndEliminationsMember 2026-04-01 2026-06-30 0000797542 QXL:SearchSegmentMember 2025-04-01 2025-06-30 0000797542 QXL:AdjustmentsAndEliminationsMember 2025-04-01 2025-06-30 0000797542 us-gaap:IntersegmentEliminationMember 2026-01-01 2026-06-30 0000797542 us-gaap:IntersegmentEliminationMember 2025-01-01 2025-06-30 0000797542 us-gaap:IntersegmentEliminationMember 2026-04-01 2026-06-30 0000797542 us-gaap:IntersegmentEliminationMember 2025-04-01 2025-06-30 0000797542 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-08 2026-07-08 0000797542 us-gaap:WarrantMember us-gaap:SubsequentEventMember QXL:TwoThousandTwentySixPIPEWarrantsMember 2026-07-09 2026-07-09 0000797542 us-gaap:CommonStockMember us-gaap:SubsequentEventMember QXL:TwoThousandTwentySixPIPEWarrantsMember 2026-07-09 2026-07-09 0000797542 us-gaap:SubsequentEventMember QXL:TwoThousandTwentySixPIPEWarrantsMember 2026-07-09 2026-07-09 0000797542 us-gaap:WarrantMember us-gaap:SubsequentEventMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2026-07-01 2026-07-31 0000797542 us-gaap:CommonStockMember us-gaap:SubsequentEventMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2026-07-01 2026-07-31 0000797542 us-gaap:SubsequentEventMember QXL:JuneTwentyTwentyFourLeadLenderFeeWarrantsMember 2026-07-01 2026-07-31 0000797542 us-gaap:SubsequentEventMember 2026-07-29 2026-07-29 0000797542 us-gaap:SubsequentEventMember 2026-07-29 iso4217:USD shares iso4217:USD shares pure QXL:Segment iso4217:ILS false Q2 --12-31 0000797542

10-Q true 2026-06-30 2026 false 001-42681 QUANTUM X LABS INC. DE 68-0080601 2 Jabotinsky St Atrium Tower 18th floor Ramat Gan IL 5252903 +972 9-774-1505 Common Stock, par value $0.0001 per share QXL NASDAQ Yes Yes Non-accelerated Filer true false false 21567826

2435000

1018000

48000

20000

281000

315000

339000

394000

299000

3497000

1652000

5000

12000

205000

56000

600000

2299000

2045000

20721000

6392000

3840000

27670000

9105000

31167000

10757000

1146000

1204000

368000 355000

268000

201000

262000

260000

781000

667000 867000 83000

472000

395000

4047000

4063000

195000

586000

416000

326000

726000

793000

1337000

1705000

0.0001

490000000

18829198

10670392

5000

4000

69945000

51032000

-44167000

-46047000

25783000

4989000

25783000

4989000

31167000

10757000

646000

899000

293000

370000

266000

184000

134000

50000

185000

36000

185000

20000

51000

50000

26000

30000

1515000

755000

1015000

558000

452000

408000

228000

235000

122000

544000

100000

500000

-1945000

-1078000

-1395000

-1023000

3831000

184000

10528000

113000

7661000

1702000

-11606000

2323000

-8684000

-110000

-25000

-94000

-67000

1812000

-11581000

2417000

-8617000

-4681000

-3801000

1812000

-16262000

2417000

-12418000

-68000

-936000

-68000

-760000

1880000

-15326000

2485000

-11658000

1880000

-11581000

2485000

-8617000

68000

1812000 -11581000 2417000 -8617000

-3745000

-3041000

936000

760000

-4681000 -3801000

0.15

-1.83

0.17

-1.19

0.10

-1.83

0.12

-1.19

-0.59

-0.42

0.15

-2.42

0.17

-1.61

0.10

-2.42

0.12

-1.61

12903662

6330104

14292085

7235599

19043862

6330104

20074625

7235599

10670392

4000

51032000

-46047000

4989000

1880000

-68000

1812000

800000 1330000 1330000 1330000

1866000

15171000

79000

15250000

11000

5492806 1000 2412000 2413000 2413000

18829198

5000

69945000

-44167000

25783000

13336392

4000

67533000

-46652000

20885000

79000

20964000

2485000

-68000

2417000

11000

5492806 1000 2412000 2413000 2413000

18829198

5000

69945000

-44167000

25783000

5296945

3000

28482000

-22714000

5771000

1736000

7507000

-15326000

-936000

-16262000

1323000

5159000

922957

11072000

1818747 1000 1819000 1820000 1820000 -4048000 -4048000 -4048000

37500

75000

3000

78000

9399163

4000

46607000

-42088000

4523000

803000

5326000

6619959

3000

33641000

-26382000

7262000

1563000

8825000

6619959

3000

33641000

-26382000

7262000

1563000

8825000

-11658000

-760000

-12418000

-11658000

-760000

-12418000

922957

11072000

1818747 1000 1819000 1820000 1820000 -4048000 -4048000 -4048000

37500

75000

9399163

4000

46607000

-42088000

4523000

803000

5326000

9399163

4000

46607000

-42088000

4523000

803000

5326000

1812000

-16262000

2417000

-12418000

-4681000

-3801000

1812000

-11581000

2417000

-8617000

452000

408000

228000

235000

75000

-55000

-32000

-27000

-24000

-41000 15000 -16000 -4000

63000

25000

38000

16000

-10121000

-7398000

6000

134000

2000

66000

3831000

-34000

-206000

-74000

-85000

60000

106000

24000

53000

-89000

-133000

403000

61000

514000

-21000 123000 -67000 -154000

-1666000

-289000

-1062000

-480000

186000

120000

193000

12000

-113000

12000

-306000

630000

200000

2000 4277000 2248000 3263000 5000 1698000

391000

1327000

195000

669000

-4000 -10000

1400000

2413000

1820000

2413000

1820000

3224000

2133000

2013000

2321000

-547000

53000

170000

27000

-377000

80000

1445000

1479000

645000

1921000

1038000

682000

1838000

240000

2483000

2161000

2483000

2161000

12000

5000

10000

4000

63000

265000

29000

124000

75000 270000 39000 128000 4048000 4048000 922000 922000 34000 67000 211000 9000

14329000

508000

-79000

-15171000 -193000 100000 3840000 11000 -3831000 120000

NOTE 1: GENERAL A. Organizational Background Quantum X Labs Inc. (formerly known as Viewbix Inc.) (the “Company”) was incorporated in the State of Delaware on August 16, 1985, under a predecessor name, The InFerGene Company (“InFerGene Company”). On August 25, 1995, a wholly owned subsidiary of InFerGene Company merged with Zaxis International, Inc., an Ohio corporation, which following such merger, the surviving entity, InFerGene Company, changed its name to Zaxis International, Inc. In 2015, the Company changed its name to Emerald Medical Applications Corp., subsequent to which the Company, through its subsidiary, was engaged in the development of technology for use in detection of skin cancer. On January 29, 2018, the Company ceased its business operations in this field. On January 17, 2018, the Company formed a new wholly owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (“VCT Israel”), to develop and market software and hardware products facilitating and supporting the purchase and/or sale of cryptocurrencies. Effective as of March 7, 2018, the Company’s name was changed from Emerald Medical Applications Corp. to Virtual Crypto Technologies, Inc. VCT Israel ceased its business operation in 2019 and prior to consummation of the Recapitalization Transaction. On January 27, 2020, VCT Israel was sold to a third party for NIS <span id="xdx_906_eus-gaap--ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_pn3n3_uNIS_c20200127__20200127__dei--LegalEntityAxis__custom--VirtualCryptoTechnologiesLtdIsraelMember_zlBNJaoLv0m4" title="Proceeds from sale">50 thousand (approximately $<span id="xdx_905_eus-gaap--ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_pn3n3_c20200127__20200127__dei--LegalEntityAxis__custom--VirtualCryptoTechnologiesLtdIsraelMember_zEyWpdHjGYI2" title="Proceeds from sale">13). On February 7, 2019, the Company entered into a share exchange agreement (the “Share Exchange Agreement” or the “Recapitalization Transaction”) with Gix Internet Ltd., a company organized under the laws of the State of Israel (“Gix” or “Former Parent Company”), pursuant to which, Gix assigned, transferred and delivered its <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190207__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GixInternetLtdMember_zQDtScn9bSPg" title="Ownership percentage">99.83% holdings in Viewbix Ltd., a company organized under the laws of the State of Israel (“Viewbix Israel”), to the Company in exchange for shares of the Company, which resulted in Viewbix Israel becoming a subsidiary of the Company. In connection with the Share Exchange Agreement, effective as of August 7, 2019, the Company’s name was changed from Virtual Crypto Technologies, Inc. to Viewbix Inc. Effective April 30, 2026, the Company. changed its name to Quantum X Labs Inc. B. Reorganization Transaction On December 5, 2021, the Company entered into a certain Agreement and Plan of Merger with Gix Media Ltd. (“Gix Media”), an Israeli company and the majority-owned (<span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GixMediaLtdMember_z8o5rPQZI5S6" title="Ownership percentage">77.92%) subsidiary of Gix, the Former Parent Company and Vmedia Merger Sub Ltd., an Israeli company and wholly-owned subsidiary of the Company (“Merger Sub”), pursuant to which, Merger Sub merged with and into Gix Media, with Gix Media being the surviving entity and a wholly-owned subsidiary of the Company (the “Reorganization Transaction”). On September 19, 2022, the Reorganization Transaction was consummated and as a result, all outstanding ordinary shares of Gix Media, having no par value (the “Gix Media Shares”) were delivered to the Company in exchange for the Company’s shares of common stock, par value $0.0001 per share (“Common Stock”). As a result of the Reorganization Transaction, the former holders of Gix Media Shares, who previously held approximately 68% of the Company’s Common Stock, hold approximately 97% of the Company’s Common Stock, and Gix Media became a wholly owned subsidiary of the Company. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 1: GENERAL (Cont.) B. Reorganization Transaction (Cont.) In connection with the closing of the Reorganization Transaction, the Company filed an Amended and Restated Certificate of Incorporation (the “Amended COI”) with the Secretary of State of Delaware, effective as of August 31, 2022, pursuant to which, concurrently with the effectiveness of the Amended COI, the Company, among other things, effected a reverse stock split of its common stock at a ratio of 1-for-28. As the Company and Gix Media were consolidated both by the Former Parent Company and Xylo Technologies Ltd. (formerly known as Medigus Ltd.) (the “Ultimate Parent”), before and after the Reorganization Transaction, the Reorganization Transaction was accounted for as a transaction between entities under common control. Accordingly, the financial information of the Company and Gix Media is presented in these financial statements, for all periods presented, reflecting the historical cost of the Company and Gix Media, as it is reflected in the consolidated financial statements of the Former Parent Company, for all periods preceding March 1, 2022, the date the Ultimate Parent obtained a controlling interest in the Former Parent Company and as it is reflected in the consolidated financial statements of the Ultimate Parent for all periods subsequent to March 1, 2022. C. Business Overview The Company and its subsidiaries (the “Group”) are focused on quantum technology, digital advertising and computing and enterprise artificial intelligence (AI) solutions. The Company, through its subsidiaries Gix Media and the former majority-owned subsidiary of Gix Media, Cortex Media Group Ltd. (“Cortex”), operates in the field of digital advertising. As of November 2025, the Company had two main activities which were reported as separate operating segments: the search segment and the digital content segment. On November 9, 2025, Gix Media sold all of its holdings in Cortex (see note 6.A). Subsequently, the Company ceased its operations in the digital content segment. The search segment develops a variety of technological software solutions, which perform automation, optimization, and monetization of internet campaigns, for the purposes of obtaining and routing internet user traffic to its customers. The search segment activity is conducted by Gix Media. The digital content segment was engaged in the creation and editing of content, in different languages, for different target audiences, for the purposes of generating revenues from leading advertising platforms, by utilizing such content to obtain and route internet user traffic for its customers. The digital content segment activity was conducted by Cortex until November 9, 2025 (see note 6.A). On March 24, 2025, the Company entered into a securities exchange agreement with Metagramm Software Ltd. (“Metagramm”) and all of the shareholders of Metagramm, pursuant to which the Company acquired <span id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20250324__us-gaap--BusinessAcquisitionAxis__custom--SecuritiesExchangeAgreementMember_zjosMBSAPsRd" title="Business acquired percentage">100% of Metagramm’s share capital in exchange for consideration equal to $<span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20250324__20250324__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zVeu72VmysWb" title="Business consideration">5,159. The consideration was paid to Metagramm’s shareholders in the form of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250324__20250324__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zJXaK7i7ZfL1" title="Number of stock issued">1,323,000 shares of common stock of the Company, representing <span id="xdx_90B_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20250324__20250324__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__srt--RangeAxis__srt--MaximumMember_zh4Xjkn2nFi3" title="Issued and outstanding share capital, percentage">19.99% of the Company’s issued and outstanding share capital (see note 6.B). QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 1: GENERAL (Cont.) C. Business Overview (Cont.) Metagramm specializes in developing advanced writing assistance tools that leverage artificial intelligence, machine learning and natural language processing technologies. Metagramm’s main product, “Bubbl” is a writing tool designed to provide personalized and customized text tailored to the user’s unique expression and can translate various languages into English. Metagramm licenses its products on a subscription basis to businesses and individual customers. On March 4, 2026, the Company completed the acquisition of Quantum X Labs Ltd. (“Quantum Israel”), a private company that operates as a multi-disciplinary quantum technology hub, pursuant to a definitive share purchase agreement dated December 15, 2025 (the “Agreement Date”). Following the acquisition, Quantum Israel became a wholly owned subsidiary of the Company. In consideration for the acquisition, the Company issued common stock and pre-funded warrants representing approximately <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20260304__us-gaap--BusinessAcquisitionAxis__custom--SecuritiesExchangeAgreementMember_zLY5dRSbgVfb" title="Business acquired percentage">40% of its capital stock as of the Agreement Date, with potential additional consideration of up to <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260304__20260304__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zlyPiFzNahw5" title="Number of stock issued">12,702,847 shares of the Company’s common stock or pre-funded warrants upon the achievement of specified post-closing milestones (see note 6.C). Quantum Israel is focused on developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum- based GPS replacement and quantum atom accuracy solutions. Its mission is to research, develop, and own quantum technology intellectual property that addresses major challenges emerging as the quantum revolution scales into commercial and industrial use. Quantum Israel combines deep academic research with practical engineering to create deployable quantum solutions. D. Impact of the War in Israel On October 7, 2023, Hamas launched a series of attacks on civilian and military targets in Southern Israel and Central Israel, to which the Israel Defense Forces responded. In addition, Iran, Hezbollah and the Houthi movement attacked military and civilian targets in Israel, to which Israel responded, including through increased air and/or ground operations in Lebanon, Syria, Yemen and Iran. Following years of conflict in the region, on October 9, 2025, Israel, Hamas, the United States and other countries in the region agreed to a framework for a ceasefire in Gaza between Israel and Hamas. On February 28, 2026, the United States and Israel launched joint combat operations in Iran to which Iran and Hezbollah responded with ballistic missile and drone attacks on Israel as well as other countries and U.S. military bases in the region. Although the United States and Iran have announced ceasefire and de-escalation arrangements from time to time, including a memorandum of understanding entered into on June 17, 2026 that contemplates the termination of military operations on multiple fronts, hostilities have resumed and may continue or escalate. How long and how severe the current conflicts in Gaza, Northern Israel, Lebanon, Iran or the broader region last and become is unknown at this time and any continued clash among Israel, Hamas, Hezbollah, Iran or other countries or militant groups in the region may escalate in the future into a greater regional conflict. The intensity and duration of the security situation in Israel have been difficult to predict, as are the economic implications on the Company’s business and operations and on Israel’s economy in general As the Group’s customers are mainly in the U.S. and Europe, its operations, revenues, and profitability are not directly affected by the security situation in Israel. However, this is an ongoing event and there is uncertainty regarding its duration, nature, and scope, management is unable to reasonably estimate the extent of the impact at this time. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 1: GENERAL (Cont.) E. Cortex Adverse Effect In April 2024, the Company was informed by Cortex that a significant customer of Cortex recently notified Cortex it will stop advertising on Cortex’s sites, as part of its policy decision to cease advertising on Made for Advertising (“MFA”) sites (the “Cortex Adverse Effect”). The Cortex Adverse Effect, which has materially affected Cortex’s business and operations, has occurred following certain recent developments relating to publishers that are categorized by a number of on-line advertisers as MFA, including decisions made by leading media on-line advertisers to prioritize different media categories and implement publishing restrictions in connection with MFA. Due to the Cortex Adverse Effect and additional circumstances as explained in note 3, the Company recorded impairments in the goodwill and intangible assets related to the digital content segment of $5,525 as of December 31, 2025. On November 9, 2025, Gix Media sold all of its holdings in Cortex (see notes 3 and 6.A). F. Filing of Insolvency Petition Against Gix Media On March 27, 2025, a petition (the “Petition”) was filed with the District Court of Tel Aviv-Jaffa (the “Court”) for a court order to commence insolvency proceedings against Gix Media. The Petition was filed by a primary service provider of Gix Media (the “Service Provider”) alleging that Gix Media owes it approximately $260 (excluding linkage differentials and interest) and that Gix Media is unable to repay its debts to the Service Provider. On July 16, 2025, the Court approved a settlement agreement entered into between Gix Media, the Service Provider and other creditors of Gix Media that joined the Petition (collectively, the “Service Providers”) with respect to the debts owed by Gix Media to the Service Providers. In connection with the settlement agreement, the Company agreed to provide a guarantee for the debts owed by Gix Media to the Service Providers. On July 22, 2025, pursuant to the terms of the settlement agreement, Gix Media paid approximately $1.13 million to the Service Providers as payment in full of the debts owed to the Service Providers. As a result of such payment in full by Gix Media to the Service Providers, the Petition was dismissed. G. Nasdaq Uplisting On June 4, 2025, the Company’s shares of common stock were approved for listing on The Nasdaq Capital Market (“Nasdaq”). The Company’s shares began trading under the symbol “VBIX” on the Nasdaq on June 5, 2025 (the “Uplist Date”). The Company’s shares were previously quoted on the OTC Markets, Pink Tier under the symbol “VBIX”, and ceased to be quoted on the OTC Markets, Pink Tier at the close of business on June 4, 2025 (the “Uplist”). As a result of the Uplist, the Company received during June and July 2025, aggregate gross proceeds of $2,852 in connection with a private placement and three facility agreements, consisting of $630 from the receipt of additional loans and $2,222 from the exercise of warrants (see notes 7.D, 7.E, 7.F and 10.B). Effective April 30, 2026, the Company changed its name from “Viewbix Inc.” to “Quantum X Labs Inc.” and its trading symbol on the Nasdaq from “VBIX” to “QXL.” QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 1: GENERAL (Cont.) H. Going Concern During the years ended December 31, 2024, and 2025 and the six months ended June 30, 2026, the Company experienced a decrease in its revenues from the digital content as a result of the Cortex Adverse Effect (see note 1.E). The Company also experienced a decrease in its revenues from the search segment, as a result of a decrease in user traffic acquired from third party advertising platforms, an industry-wide decrease in advertising budget, changes and updates to internet browsers’ technology, which adversely impacted the Company’s ability to acquire traffic in the search segment and a decrease in revenues from routing of traffic acquired from third-party strategic partners in the search segment, following the lack of availability of suppliers credit from such third party strategic partners. As a result of the foregoing, during the six months ended June 30, 2026, the Company recorded an operating loss from continuing operations of $1,945 compared to $1,078 during the six months ended June 30, 2025. As of June 30, 2026, the Company had cash and cash equivalents of $2,435, bank loans of $1,238 and accumulated deficit of $44,167. The decline in revenues and other circumstances described above raise substantial doubts about the Company’s ability to continue as a going concern during the 12-month period following the issuance date of these financial statements. Management’s response to these conditions included reduction of salaries and related expenses and reduction of professional services in the research and development and selling and marketing functions, reduction of other operational expenses, such as lease costs and overheads, as well as creation of new partnerships and other new income sources. In addition, the Company raised funds during 2025, increasing its cash balance, as follows: (1) pursuant to the consummation of the Uplist (as described in note 1.G above), the Company received during June and July 2025, aggregate gross proceeds of $2,852 in connection with a private placement (see note 10.B) and three facility agreements (see notes 7.D, 7.E, 7.F), consisting of $630 from the receipt of additional loans and $2,222 from the exercise of warrants and (2) on July 14, 2025, the Company closed an additional private placement transaction with certain accredited investors, pursuant to which the Company received gross proceeds of $4.5 million (see note 10.C). Moreover, on March 4, 2026, the Company closed a private placement transaction with certain accredited investors, pursuant to which the Company received gross proceeds of $1.4 million (see note 10.D) and during June and July 2026, the Company received total proceeds of $2,413 and $1,505, respectively, from the exercise of warrants (see notes 10.A, 10.C, 10.D, 12.A and 12.C). Notwithstanding the foregoing, there remains uncertainty as to whether the Company will be able to secure additional funding when needed. Such conditions raise substantial doubts about the Company’s ability to continue as a going concern for at least a year after the issuance date of the accompanying financial statements. These financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data)

50000

13000

0.9983

0.7792

0.0001

As a result of the Reorganization Transaction, the former holders of Gix Media Shares, who previously held approximately 68% of the Company’s Common Stock, hold approximately 97% of the Company’s Common Stock, and Gix Media became a wholly owned subsidiary of the Company.

1-for-28

5159000

1323000

0.1999

0.40

12702847

5525000

260000

1130000

2852000

630000

2222000

-1945000

-1078000

2435000

1238000

-44167000

2852000

630000

2222000

4500000

1400000

2413000

1505000

NOTE 2: SIGNIFICANT ACCOUNTING POLICIES A. Unaudited Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Group’s Annual Report on Form 10-K for the year ended December 31, 2025. B. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. C. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock-based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 2: SIGNIFICANT ACCOUNTING POLICIES (Cont.) D. Significant Accounting Policies The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements. E. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Group’s interim condensed consolidated financial statements.

A. Unaudited Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Group’s Annual Report on Form 10-K for the year ended December 31, 2025.

B. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

C. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock-based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 2: SIGNIFICANT ACCOUNTING POLICIES (Cont.)

D. Significant Accounting Policies The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.

E. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Group’s interim condensed consolidated financial statements.

NOTE 3: DISCONTINUED OPERATIONS On November 9, 2025, Gix Media sold all of its holdings in Cortex (see note 6.A), following which the Group ceased its operations in the digital content segment activity. The Company has determined that the sale of Cortex has a major effect on the Company’s operations and financial results. In this respect, the results of operations and cash flows of the digital content segment, as well as its assets and liabilities, are reported as discontinued operations. The comparative figures in these consolidated financial statements have been adjusted on the basis of presenting separately the discontinued operations’ figures. <p id="xdx_89E_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zOIff09owoo8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The components of the loss from discontinued operations for the six and three months ended June 30, 2025, in the consolidated statements of income consisted of the following: SCHEDULE OF DISCONTINUED OPERATIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20250630_zakB1I5Lxpa8" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20250401__20250630_zn0nILnuCl44" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_zEViENqsOhi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">4,115</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,911</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Costs and Expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationTrafficAcquisitionAndRelatedCosts_pn3n3_zq7JyzFauM0c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Traffic-acquisition and related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,019</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,830</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_pn3n3_zQxF2fy9Pung" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketing_pn3n3_zj20vaPx1Dga" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_pn3n3_zZyyFi4vGhFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_pn3n3_zmuefVA1q2r8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,092</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">546</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationImpairmentOfIntangibleAssetsAndGoodwill_pn3n3_zZpTjmg78SP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Impairment of intangible assets and goodwill (a)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,150</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,150</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_iT_pn3n3_z1QBYli8KOej" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,812</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,898</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationFinancialIncomeNet_pn3n3_ztx8G80uojN8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Financial income, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(39</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_iT_pn3n3_zk9f3hsHVJqk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loss from discontinued operations before taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,809</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,859</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_iN_pn3n3_di_zCZAhD22K1qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Income tax benefit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(128</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iNT_pn3n3_di_z0zFbscrehQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4,681</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,801</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As of June 30, 2025, the Company identified indicators of impairment of the digital content reporting unit. As a result, the Company performed an impairment test which included a quantitative analysis of the fair value of the reporting unit. The fair value was estimated using the income approach, which is based on the present value of the future cash flows attributable to the reporting unit. The Company compared the fair value of the reporting unit to its carrying amount. As the carrying amount exceeded the fair value, the Company recognized an impairment loss of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIERJU0NPTlRJTlVFRCBPUEVSQVRJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--GainLossOnDispositionOfRealEstateDiscontinuedOperations_pn3n3_c20250101__20250630_zJOl8YrIM9zk" title="Recognized an impairment loss">3,150 which was driven mainly due to the Cortex Adverse Effect (see note 1.E) and due to a decrease in the cash flow projections.</td></tr> </table> QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data)

<p id="xdx_89E_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zOIff09owoo8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The components of the loss from discontinued operations for the six and three months ended June 30, 2025, in the consolidated statements of income consisted of the following: SCHEDULE OF DISCONTINUED OPERATIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20250630_zakB1I5Lxpa8" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20250401__20250630_zn0nILnuCl44" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_zEViENqsOhi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">4,115</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,911</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Costs and Expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationTrafficAcquisitionAndRelatedCosts_pn3n3_zq7JyzFauM0c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Traffic-acquisition and related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,019</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,830</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_pn3n3_zQxF2fy9Pung" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketing_pn3n3_zj20vaPx1Dga" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_pn3n3_zZyyFi4vGhFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_pn3n3_zmuefVA1q2r8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,092</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">546</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationImpairmentOfIntangibleAssetsAndGoodwill_pn3n3_zZpTjmg78SP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Impairment of intangible assets and goodwill (a)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,150</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,150</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_iT_pn3n3_z1QBYli8KOej" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,812</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,898</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationFinancialIncomeNet_pn3n3_ztx8G80uojN8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Financial income, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(39</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_iT_pn3n3_zk9f3hsHVJqk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loss from discontinued operations before taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,809</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,859</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_iN_pn3n3_di_zCZAhD22K1qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Income tax benefit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(128</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iNT_pn3n3_di_z0zFbscrehQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4,681</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,801</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As of June 30, 2025, the Company identified indicators of impairment of the digital content reporting unit. As a result, the Company performed an impairment test which included a quantitative analysis of the fair value of the reporting unit. The fair value was estimated using the income approach, which is based on the present value of the future cash flows attributable to the reporting unit. The Company compared the fair value of the reporting unit to its carrying amount. As the carrying amount exceeded the fair value, the Company recognized an impairment loss of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIERJU0NPTlRJTlVFRCBPUEVSQVRJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--GainLossOnDispositionOfRealEstateDiscontinuedOperations_pn3n3_c20250101__20250630_zJOl8YrIM9zk" title="Recognized an impairment loss">3,150 which was driven mainly due to the Cortex Adverse Effect (see note 1.E) and due to a decrease in the cash flow projections.</td></tr> </table>

4115000

1911000

4019000 1830000 236000 105000 356000 160000

74000

18000

1092000

546000

3150000 3150000

4812000

3898000

-3000 -39000

4809000

3859000

128000

58000

-4681000

-3801000

3150000

NOTE 4: LOAN TO FORMER PARENT COMPANY On March 22, 2020, Gix Media entered into a loan agreement with the Former Parent Company. The loan bore interest at a rate determined from time to time in accordance with Section 3(j) of the Income Tax Ordinance, new version, and the Income Tax Regulations (Determination of Interest Rate for the purposes of Section 3(j), 1986). On April 10, 2025, the Company’s board of directors approved the redemption of the loan between Gix Media and the Former Parent Company. As a result, Gix Media and the Former Parent Company entered into a redemption agreement, effective as of May 27, 2025, pursuant to which the outstanding loan was redeemed in consideration for the transfer to Gix Media of all of the Former Parent Company’s intangible assets, including, inter alia, intellectual property rights, trademarks, software, algorithms, domains, technological know-how and any other intangible asset (the “Redemption”). Since this transaction is between entities under common control, the intangible assets received from the Former Parent Company were recorded at their historical carrying amount as they were recorded at the Former Parent Company’s financial statements which is $0. As a result, the outstanding loan amount including accrued interest, totaling $4,048, was redeemed in full. The Redemption was recorded as an increase to the accumulated deficit in the Company’s statement of changes in shareholders’ equity for the period ended June 30, 2025. For the six months ended June 30, 2025, Gix Media recognized interest income in the amount of $63.

4048000

63000

NOTE 5: GOODWILL AND INTANGIBLE ASSETS, NET <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Composition:</td></tr> </table> SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_z9cxKjsKcpR8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">In-process research and development</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternalSoftwareMember_zRN2eFFUIaS3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Internal-use Software</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationsMember_zIQjYLRzqxg7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Customer Relations</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyMember_zGoMmQwYAXh7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Technology</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zaXvTyAouu6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260101__20260630_zEncwpYwdF3l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pn3n3_zvDHARxxW8e2" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-weight: bold">Balance as of January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">1,260</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">3,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">6,392</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">11,190</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_z8HZfWaglv2b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Consolidation of Quantum Israel (note 6.C)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">14,329</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">14,989</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pn3n3_z4NECmUX0SLi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of June 30, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,260</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,721</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26,179</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Accumulated amortization:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pn3n3_zY4QHH8iBLYa" style="vertical-align: bottom; background-color: White"> <td>Balance as of January 1, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">592</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,696</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,753</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_zd6egZ03IdD1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization recognized during the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">140</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">266</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">406</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pn3n3_zV01XR14Su17" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of June 30, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">732</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,962</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,159</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Amortized cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iE_pn3n3_zQrTzeoeL57e" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">As of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">528</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">20,721</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">23,020</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternalSoftwareMember_zVsn5ao2tCHa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Internal-use Software</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationsMember_zfMmLZHkOHsh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Customer Relations</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyMember_z6OhHxP06O21" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Technology</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zfkTRR6t8qI1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20250101__20251231_zG1caXDaWqB9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pn3n3_z4MowjW3gZH5" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; font-weight: bold">Balance as of January 1, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,523</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,083</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">4,941</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pn3n3_zpoIAPTgKCu8" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Cost, beginning balance </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,083</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,941</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_zfoFL0Wbelcb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Consolidation of Metagramm (note 6.B)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">390</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">550</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,309</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,249</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pn3n3_zjHCKFEojvhd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,260</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,392</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,190</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pn3n3_z77kLt6B7Lib" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Cost, ending balance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,260</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,392</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,190</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Accumulated amortization:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pn3n3_zLRN0P6ryx14" style="vertical-align: bottom; background-color: White"> <td>Balance as of January 1, 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">351</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,972</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pn3n3_zf06HNmjcCS6" style="display: none; vertical-align: bottom; background-color: White"> <td>Accumulated amortization, beginning balance </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">351</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,972</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_zNfFAmrmdj44" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization recognized during the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">241</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">504</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">781</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pn3n3_zmEwYYheqQn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">592</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,696</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,753</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pn3n3_zD5TZCOIPM3g" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Accumulated amortization, ending balance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">592</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,696</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,753</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Amortized cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iE_pn3n3_zWk9FYi2Xob9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">As of December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">668</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,377</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,392</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iE_pn3n3_zHXhdAlRzUS8" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Amortized cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">668</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,377</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,392</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 5: GOODWILL AND INTANGIBLE ASSETS, NET (Cont.) B. Impairment of intangible assets and goodwill: As of December 31, 2025, the Company performed a quantitative impairment test of the search reporting unit. The Company did not recognize impairment losses regarding this reporting unit for the year ended December 31, 2025.

SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_z9cxKjsKcpR8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">In-process research and development</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternalSoftwareMember_zRN2eFFUIaS3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Internal-use Software</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationsMember_zIQjYLRzqxg7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Customer Relations</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyMember_zGoMmQwYAXh7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Technology</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260101__20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zaXvTyAouu6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260101__20260630_zEncwpYwdF3l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pn3n3_zvDHARxxW8e2" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-weight: bold">Balance as of January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">1,260</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">3,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">6,392</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">11,190</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_z8HZfWaglv2b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Consolidation of Quantum Israel (note 6.C)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">14,329</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">14,989</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pn3n3_z4NECmUX0SLi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of June 30, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,260</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,721</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26,179</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Accumulated amortization:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pn3n3_zY4QHH8iBLYa" style="vertical-align: bottom; background-color: White"> <td>Balance as of January 1, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">592</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,696</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,753</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_zd6egZ03IdD1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization recognized during the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">140</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">266</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">406</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pn3n3_zV01XR14Su17" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of June 30, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">732</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,962</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,159</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Amortized cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iE_pn3n3_zQrTzeoeL57e" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">As of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">528</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">20,721</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">23,020</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternalSoftwareMember_zVsn5ao2tCHa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Internal-use Software</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationsMember_zfMmLZHkOHsh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Customer Relations</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyMember_z6OhHxP06O21" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Technology</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zfkTRR6t8qI1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20250101__20251231_zG1caXDaWqB9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pn3n3_z4MowjW3gZH5" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; font-weight: bold">Balance as of January 1, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,523</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,083</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">4,941</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pn3n3_zpoIAPTgKCu8" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Cost, beginning balance </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,083</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,941</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_zfoFL0Wbelcb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Consolidation of Metagramm (note 6.B)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">390</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">550</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,309</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,249</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pn3n3_zjHCKFEojvhd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,260</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,392</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,190</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pn3n3_z77kLt6B7Lib" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Cost, ending balance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,260</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,392</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,190</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Accumulated amortization:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pn3n3_zLRN0P6ryx14" style="vertical-align: bottom; background-color: White"> <td>Balance as of January 1, 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">351</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,972</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pn3n3_zf06HNmjcCS6" style="display: none; vertical-align: bottom; background-color: White"> <td>Accumulated amortization, beginning balance </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">351</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,972</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_zNfFAmrmdj44" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization recognized during the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">241</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">504</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">781</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pn3n3_zmEwYYheqQn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Balance as of December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">592</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,696</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,753</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pn3n3_zD5TZCOIPM3g" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Accumulated amortization, ending balance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">465</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">592</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,696</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,753</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Amortized cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iE_pn3n3_zWk9FYi2Xob9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">As of December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">668</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,377</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,392</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iE_pn3n3_zHXhdAlRzUS8" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Amortized cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">668</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,377</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,392</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

465000

1260000

3073000

6392000

11190000

660000

14329000

14989000

660000

465000

1260000

3073000

20721000

26179000

465000

592000

1696000

2753000

140000

266000

406000

465000

732000

1962000

3159000

660000

528000

1111000

20721000

23020000

465000

870000

2523000

1083000

4941000

465000

870000

2523000

1083000

4941000

390000

550000

5309000

6249000

465000

1260000

3073000

6392000

11190000

465000

1260000

3073000

6392000

11190000

429000

351000

1192000

1972000

429000

351000

1192000

1972000

36000

241000

504000

781000

465000

592000

1696000

2753000

465000

592000

1696000

2753000

668000

1377000

6392000

8437000

668000

1377000

6392000

8437000

NOTE 6: BUSINESS COMBINATION A. Cortex Acquisition and Sale On October 13, 2021, <span id="xdx_902_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211013__20211013__us-gaap--BusinessAcquisitionAxis__custom--CortexAcquisitionMember_z7OaKifhYW11" title="Business acquisition description of acquired entity">Gix Media acquired 70% (on a fully diluted basis) of the shares of Cortex (the “Cortex Transaction”), a private company operating in the field of online media and advertising. In consideration for the Cortex Transaction, Gix Media paid NIS 35 million in cash (approximately $11 million). The Cortex Transaction was financed by Gix Media’s existing cash balances and substantially by debt through a bank financing in the aggregate amount of $9.5 million, that consists of a line of credit of up to $3.5 million and a long-term loan of $6 million (see note 7.B). On January 23, 2023, Gix Media acquired an additional <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20230123__us-gaap--BusinessAcquisitionAxis__custom--GixMediaLtdMember_z4Qn4sJkEnsk" title="Business acquire percentage">10% of Cortex, increasing its holdings to <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20230123__us-gaap--BusinessAcquisitionAxis__custom--CortexAcquisitionMember_zlSCLzOW4mFl" title="Business acquire percentage">80% of the share capital of Cortex in consideration for $2.6 million. On November 9, 2025 (the “Cortex Closing Date”), Gix Media, Cortex, and certain founders of Cortex entered into a share purchase agreement (the “Cortex Sale Agreement”) with Pro Sportority (Israel) Ltd. (the “Purchaser”), a subsidiary of Minute Media Inc. (the “Parent”). Pursuant to the Cortex Sale Agreement, the Purchaser acquired from Gix Media all of its holdings in Cortex, representing <span id="xdx_902_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20251109__20251109__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GixMediaLtdMember_zeUK9d4Z2AF5" title="Issued and outstanding share capital, percentage">80% of Cortex’s issued and outstanding share capital. The aggregate consideration paid to Gix Media was $<span id="xdx_90E_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20251109__20251109__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GixMediaLtdMember_zpekfgnCmrp2" title="Business consideration">800, consisting of (i) $<span id="xdx_903_eus-gaap--Cash_iI_pn3n3_c20251109__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GixMediaLtdMember_zzknD1JehMPe" title="Business consideration, cash">200 in cash, and (ii) $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20251109__20251109__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GixMediaLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zugWG5JD3xma" title="Shares issued, value">600 in the form of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20251109__20251109__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GixMediaLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zO96gNSnvkjl" title="Shares issued">5,161 newly issued Preferred J Shares of the Parent (the “Parent Shares”), the most senior class of preferred shares of the Parent. The Parent retains a call option to repurchase the Parent Shares from Gix Media under certain conditions, including insolvency or a change of control of Gix Media. In addition, Gix Media is subject to a two-year non-compete and non-solicitation covenant following the Cortex Closing Date. B. Metagramm Acquisition: On March 24, 2025 (the “Closing Date”), the Company entered into a securities exchange agreement with Metagramm and all of the shareholders of Metagramm (the “2025 SEA”). Pursuant to the 2025 SEA, the Company acquired <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20250324__us-gaap--BusinessAcquisitionAxis__custom--SecuritiesExchangeAgreementMember_zqOt0YsKdtC9" title="Business acquired percentage">100% of Metagramm’s shares in exchange for consideration of $<span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20250324__20250324__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zkBQOC7pRJwd" title="Business consideration">5,159. The consideration was paid to Metagramm’s shareholders in the form of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250324__20250324__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zFAL6WQIr4th" title="Number of stock issued">1,323,000 shares of common stock of the Company, representing <span id="xdx_90B_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20250324__20250324__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__srt--RangeAxis__srt--MaximumMember_zu2Bnc5VjKdj" title="Issued and outstanding share capital, percentage">19.99% of the Company’s issued and outstanding share capital immediately following the acquisition (the “Metagramm Acquisition”). In addition, the Company agreed to pay Metagramm’s shareholders cash earn-out payments on a pro rata basis of up to a cumulative sum of $<span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_pn5n6_c20250324__20250324__us-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_znQfhLuV3rX5" title="Cash earn-out payments">2.0 million, contingent on achieving certain financing and revenue milestones within 3 years following the Closing Date (see notes 10.C, 10.D). QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 6: BUSINESS COMBINATION (Cont.) B. Metagramm Acquisition: (Cont.) <p id="xdx_89B_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_z2s8OtgPxu6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Fair Value of Metagramm’s Identifiable Assets and Liabilities: SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20250324__us-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_zMka2f02Hmbd" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maAzkbZ_z1g3XUl7KJff" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">12</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3_maAzkbZ_zZEvFK1ZaZy5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--NetWorkingCapitalOtherThanCashAndRestrictedDeposits_iI_pn3n3_maAzkbZ_zgmQbp4ZKp07" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Net working capital other than cash and restricted deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_maAzkbZ_zORSgLd5Oyhf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">106</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3_maAzkbZ_z06cQ4BVEbD4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Goodwill arising from the acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,309</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyNetOfDeferredTaxes_iI_pn3n3_maAzkbZ_zKLDxtuOlP31" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Technology, net of deferred taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">424</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInprocessResearchAndDevelopmentNetOfDeferredTaxes_iI_pn3n3_maAzkbZ_zqHhN8u1D90d" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">In-process research and development, net of deferred taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--MinorityInterest_iI_pn3n3_msAzkbZ_zmb31R0hqfDk" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-controlling interests</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationsNetOfDeferredTaxes_pn3n3_maAzkbZ_zrVgas10XTnj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Customer Relations, net of deferred taxes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">300</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_pn3n3_mtAzkbZ_msACzT1W_ziOhQyCZeD1g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total cost of the acquisition</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,169</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEarnoutLiabilityArisingFromAcquisition_iI_pn3n3_maLzbXo_zoru73lYM2J8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Earn-out liability arising from the acquisition</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,010</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iTI_pn3n3_mtLzbXo_maACzT1W_zXZSOvwGVvLe" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,010</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConsiderationPaidInCompanysSharesAndPrefundedWarrants_iNI_pn3n3_di_zApnkvtqTca1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Consideration paid in Company’s shares and pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ContingentConsiderationTransferredInCompanysPrefundedWarrants_iNI_pn3n3_di_zfHPbRl8rb2g" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration to be paid in Earn-Out Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AcquisitionCost_iNTI_pn3n3_di_mtACzT1W_zglbbvIHZuT1" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consideration paid in Company’s shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,159</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The total consideration has been allocated between assets acquired and liabilities assumed based on estimated fair values, with the residual of the total consideration recorded as goodwill. The goodwill that arose from the acquisition consists of synergies expected from the activities of the Company and Metagramm. The estimation of the fair value of these intangible assets was determined using the income approach, which is based on the present value of the future cash flows attributable to each identifiable intangible asset. The estimation of the fair value of the earn-out liability was calculated based on Monte Carlo method. Other current assets were estimated to have fair values that approximate their carrying values due to the short-term maturities of these instruments. The estimated useful lives for the acquired technology and customer relations of Metagramm Acquisition are <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250324__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyMember__us-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_z3IDDTaMoBel" title="Estimated useful lives">5 years and <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250324__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationsMember__us-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_zbbHJsHczPr8" title="Estimated useful lives">2.5 years, respectively. The goodwill will not be deductible for income tax purposes. C. Quantum Israel Acquisition: On December 15, 2025, the Company entered into a securities exchange agreement (the “Quantum Exchange Agreement”) with Quantum Israel and certain shareholders of Quantum Israel (the “Quantum Israel Shareholders”) pursuant to which the Company agreed to issue to the Quantum Israel Shareholders an aggregate amount of up to <span id="xdx_903_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGn0dolPxCo2" title="Issued and outstanding share capital, percentage">40.0% of the Company’s issued and outstanding capital stock as of December 15, 2025, inclusive of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc6SYi74T6hg" title="Shares issued">800,000 shares of the Company’s common stock issuable by the Company in a private placement offering (the “Private Placement Shares”) that the Company entered into in January 2026 (see also note 10.D), consisting of (i) up to <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20251101__20251130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhkdL9vDXpAe" title="Shares issued">2,666,000 shares of the Company’s common stock, representing <span id="xdx_903_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20251101__20251130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zd5hsKtvDs9a" title="Issued and outstanding share capital, percentage">19.99% of the Company’s issued and outstanding capital stock (the “Exchange Shares”), inclusive of the Private Placement Shares, and (ii) pre-funded warrants to purchase up to <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20251130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zviLHMe2I6v2" title="Purchase of warrants">4,447,595 shares of the Company’s common stock, representing the balance of up to the <span id="xdx_903_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20251101__20251130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z6TLRUk1n4n9" title="Issued and outstanding share capital, percentage">40.0%, as of December 15, 2025, less the Exchange Shares, in exchange for up to <span id="xdx_908_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember_zd9AEK84AN4f" title="Issued and outstanding share capital, percentage">100%, but not less than <span id="xdx_90E_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zPcLKok5esH7" title="Issued and outstanding share capital, percentage">85%, of Quantum Israel’s issued and outstanding share capital on a fully diluted and post-closing basis, equal to an amount up to <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNSJrtRb9cxk" title="Shares issued in transaction">589,319 of Quantum Israel’s ordinary shares (the “Quantum Israel Acquisition”). QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 6: BUSINESS COMBINATION (Cont.) C. Quantum Israel Acquisition: (Cont.) In addition, pursuant to the Quantum Exchange Agreement, the Company may issue to the Quantum Israel Shareholders up to <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zflam4zzXdA6" title="Shares issued in transaction">12,702,847 additional shares of the Company’s common stock or pre-funded warrants to purchase shares of the Company’s common stock (collectively, the “Earn-Out Securities”), only following the 12-month anniversary of the closing date of the Quantum Israel Acquisition and upon the achievement of specified post-closing milestones as defined in the Quantum Exchange Agreement. On March 4, 2026, the Company closed the Quantum Israel Acquisition (the “Quantum Closing Date”), pursuant to which the Company acquired <span id="xdx_907_eus-gaap--SaleOfStockPercentageOfOwnershipBeforeTransaction_pid_dp_uPure_c20260304__20260304__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_zOmfsZznQhng" title="Acquired percentage">100% of Quantum Israel’s issued and outstanding share capital on a fully diluted, post-closing basis and Quantum Israel became a wholly owned subsidiary of the Company. On the Quantum Closing Date, the Company issued to the Quantum Israel Shareholders <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260304__20260304__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxohkfFiuNo1" title="Number of shares issued">1,866,000 shares of its common stock and pre-funded warrants to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260304__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_zt6Uvl0WhVmj" title="Number of warrants issued">4,447,595 shares of its common stock. The pre-funded warrants were exercisable upon issuance at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260304__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_z7Q6sWGgE75g" title="Exercise price">0.0001 per share and will not expire until exercised in full. <p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--QuantumIsraelMember_zkSxQ9H8b4Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Fair Value of Quantum Israel’s Identifiable Assets and Liabilities: SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20250304__us-gaap--BusinessAcquisitionAxis__custom--QuantumIsraelMember_zw506HZtXANd" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maAzkbZ_zJHKAqBTVeKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Cash and cash equivalents and restricted deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">193</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--NetWorkingCapitalOtherThanCashAndRestrictedDeposits_iI_pn3n3_maAzkbZ_zahJILfygIf5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net working capital other than cash and restricted deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">211</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_maAzkbZ_z0uD2z7oQMW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3_maAzkbZ_zNIe48uQN5Wh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Goodwill arising from the acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,329</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInprocessResearchAndDevelopmentNetOfDeferredTaxes_iI_pn3n3_maAzkbZ_zqrJGWAWv7vi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">In-process research and development, net of deferred taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">508</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--MinorityInterest_iNI_pn3n3_di_msAzkbZ_zDwZibQ1m21c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-controlling interests</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(79</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_pn3n3_mtAzkbZ_zw1B0K2AP7Wd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Total cost of the acquisition</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">15,171</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ConsiderationPaidInCompanysSharesAndPrefundedWarrants_iNI_pn3n3_di_maACzT9N_zfqKB65NZTWe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Consideration paid in Company’s shares and pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,670</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ContingentConsiderationTransferredInCompanysPrefundedWarrants_iNI_pn3n3_di_maACzT9N_zYsxhd7rbFpa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration to be paid in Earn-Out Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,501</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--AcquisitionCost_iNTI_pn3n3_di_mtACzT9N_zt4q8SyatVj4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Total Consideration</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">15,171</td><td style="font-weight: bold; text-align: left"> </td></tr> </table> The total consideration was allocated to the fair value of assets acquired and liabilities assumed as of the Quantum Closing Date, with the excess purchase price recorded as goodwill. The goodwill will not be deductible for income tax purposes. Management’s estimate of the fair value of the acquired in-process research and development and the contingent consideration to be paid upon achieving certain milestones assumed as of the Quantum Closing Date is preliminary and subject to change and is based on established and accepted valuation techniques performed with the assistance of third-party valuation specialists. Changes to amounts will be recorded as adjustments to the provisional amounts recognized as of the Quantum Closing Date and may result in a corresponding adjustment to goodwill during the remainder of the measurement period, which will not exceed twelve months from the Quantum Closing Date. The estimation of the fair value of in-process research and development was determined using the income approach, which is based on the present value of the future cash flows attributable to the identifiable intangible asset. The contingent consideration of $<span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iI_pn3n3_c20260304__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_z4syMWOxApvl" title="Contingent consideration">4,501 represents the estimated fair value of the contingent consideration to be paid in Earn-Out Securities to the Quantum Israel Shareholders upon the achievement of certain milestones during the 12-month anniversary of the Quantum Closing Date. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 6: BUSINESS COMBINATION (Cont.) D. Deconsolidation of CliniQuantum As of the Quantum Closing Date, CliniQuantum Ltd. (“CliniQuantum”) was a subsidiary of Quantum Israel. On June 3, 2026, a third-party completed the acquisition of 54.01% of the issued and outstanding ordinary shares of CliniQuantum from certain CliniQuantum shareholders, following which Quantum Israel lost control of CliniQuantum. Upon loss of control, Quantum Israel determined that it exercised significant influence over CliniQuantum. Accordingly, the investment in CliniQuantum was accounted for under the equity method and measured at its fair value of $<span id="xdx_90D_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20260603__us-gaap--InvestmentCompanyNonconsolidatedSubsidiaryAxis__custom--CliniQuantumLtdMember_zI0P0QstovOe" title="Fair value of investments">3,840. The fair value of the investment in CliniQuantum was determined based on a valuation that reflects transactions in CliniQuantum shares. As a result, the Company recognized a gain from deconsolidation of $<span id="xdx_901_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20260603__20260603__us-gaap--InvestmentCompanyNonconsolidatedSubsidiaryAxis__custom--CliniQuantumLtdMember_zJRsE2awlTi" title="Gain from deconsolidation">3,831 in the condensed consolidated statements of operations for the six months ended June 30, 2026. Quantum Israel is in the process of allocating the difference between the carrying amount of its investment in CliniQuantum and its proportionate share of CliniQuantum’s underlying net assets to the identifiable assets and liabilities of CliniQuantum. While Quantum Israel used its best estimates and assumptions as part of this allocation process to accurately value the CliniQuantum’s assets and liabilities, these estimates are inherently uncertain and subject to refinement as the guidance allows a measurement period of up to one year from June 3, 2026, to make adjustments to this preliminary allocation. Since Quantum Israel elected to recognize the proportionate share of its equity method, there was no impact from these allocations on the Company’s condensed consolidated statements of operations for the six months ended June 30, 2026.

Gix Media acquired 70% (on a fully diluted basis) of the shares of Cortex (the “Cortex Transaction”), a private company operating in the field of online media and advertising. In consideration for the Cortex Transaction, Gix Media paid NIS 35 million in cash (approximately $11 million). The Cortex Transaction was financed by Gix Media’s existing cash balances and substantially by debt through a bank financing in the aggregate amount of $9.5 million, that consists of a line of credit of up to $3.5 million and a long-term loan of $6 million (see note 7.B).

9500000

3500000

6000000

0.10

0.80

2600000

0.80

800000

200000

600000

5161

5159000

1323000

0.1999

2000000.0

<p id="xdx_89B_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_z2s8OtgPxu6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Fair Value of Metagramm’s Identifiable Assets and Liabilities: SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20250324__us-gaap--BusinessAcquisitionAxis__custom--MetagrammSoftwareLtdMember_zMka2f02Hmbd" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maAzkbZ_z1g3XUl7KJff" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">12</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3_maAzkbZ_zZEvFK1ZaZy5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--NetWorkingCapitalOtherThanCashAndRestrictedDeposits_iI_pn3n3_maAzkbZ_zgmQbp4ZKp07" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Net working capital other than cash and restricted deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_maAzkbZ_zORSgLd5Oyhf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">106</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3_maAzkbZ_z06cQ4BVEbD4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Goodwill arising from the acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,309</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyNetOfDeferredTaxes_iI_pn3n3_maAzkbZ_zKLDxtuOlP31" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Technology, net of deferred taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">424</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInprocessResearchAndDevelopmentNetOfDeferredTaxes_iI_pn3n3_maAzkbZ_zqHhN8u1D90d" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">In-process research and development, net of deferred taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--MinorityInterest_iI_pn3n3_msAzkbZ_zmb31R0hqfDk" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-controlling interests</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationsNetOfDeferredTaxes_pn3n3_maAzkbZ_zrVgas10XTnj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Customer Relations, net of deferred taxes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">300</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_pn3n3_mtAzkbZ_msACzT1W_ziOhQyCZeD1g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total cost of the acquisition</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,169</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEarnoutLiabilityArisingFromAcquisition_iI_pn3n3_maLzbXo_zoru73lYM2J8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Earn-out liability arising from the acquisition</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,010</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iTI_pn3n3_mtLzbXo_maACzT1W_zXZSOvwGVvLe" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,010</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConsiderationPaidInCompanysSharesAndPrefundedWarrants_iNI_pn3n3_di_zApnkvtqTca1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Consideration paid in Company’s shares and pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ContingentConsiderationTransferredInCompanysPrefundedWarrants_iNI_pn3n3_di_zfHPbRl8rb2g" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration to be paid in Earn-Out Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AcquisitionCost_iNTI_pn3n3_di_mtACzT1W_zglbbvIHZuT1" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consideration paid in Company’s shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,159</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

12000

18000

106000

5309000

424000 300000

6169000

1010000

-5159000

P5Y

P2Y6M

0.400

800000

2666000

0.1999

4447595

0.400 1 0.85

589319

12702847

1866000

4447595

0.0001

<p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--QuantumIsraelMember_zkSxQ9H8b4Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Fair Value of Quantum Israel’s Identifiable Assets and Liabilities: SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20250304__us-gaap--BusinessAcquisitionAxis__custom--QuantumIsraelMember_zw506HZtXANd" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maAzkbZ_zJHKAqBTVeKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Cash and cash equivalents and restricted deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">193</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--NetWorkingCapitalOtherThanCashAndRestrictedDeposits_iI_pn3n3_maAzkbZ_zahJILfygIf5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net working capital other than cash and restricted deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">211</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_maAzkbZ_z0uD2z7oQMW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3_maAzkbZ_zNIe48uQN5Wh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Goodwill arising from the acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,329</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInprocessResearchAndDevelopmentNetOfDeferredTaxes_iI_pn3n3_maAzkbZ_zqrJGWAWv7vi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">In-process research and development, net of deferred taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">508</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--MinorityInterest_iNI_pn3n3_di_msAzkbZ_zDwZibQ1m21c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-controlling interests</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(79</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_pn3n3_mtAzkbZ_zw1B0K2AP7Wd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Total cost of the acquisition</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">15,171</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ConsiderationPaidInCompanysSharesAndPrefundedWarrants_iNI_pn3n3_di_maACzT9N_zfqKB65NZTWe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Consideration paid in Company’s shares and pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,670</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ContingentConsiderationTransferredInCompanysPrefundedWarrants_iNI_pn3n3_di_maACzT9N_zYsxhd7rbFpa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration to be paid in Earn-Out Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,501</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--AcquisitionCost_iNTI_pn3n3_di_mtACzT9N_zt4q8SyatVj4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Total Consideration</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">15,171</td><td style="font-weight: bold; text-align: left"> </td></tr> </table>

193000

211000

9000

14329000

508000

79000

15171000

-10670000 -4501000 -15171000

4501000

3840000

3831000

NOTE 7: LOANS A. Composition of long-term loans, short-term loans, and credit lines of the Group: The following is the composition of the balance of the Group’s loans according to their nominal value: SCHEDULE OF COMPOSITION OF BALANCE OF GROUP’S LOANS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest rate</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260630_zQX5PGDpkUI3" style="border-bottom: Black 1pt solid; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20251231_zqeyoTaTHPM1" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--LoansPayableToBankCurrent_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zMp1M9fo9VKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Short-term bank loans – Gix Media</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_ztmQcb0EqN1f" title="Debt instrument description"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zvnobnfMffci" title="Debt instrument description">SOFR + 4.95</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">260</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LoansPayableToBankCurrent_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zTIpPEiCzeac" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Short-term bank loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zpTiGAh39QV6" title="Debt instrument description"><span id="xdx_900_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_ziaIUyFHGWWk" title="Debt instrument description">SOFR + 4.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">260</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermLoansFromBank_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zYd4FBIZYaNb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Long-term bank loan, including current maturity – Gix Media (received on July 10, 2025)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_ztx0tGMnDqme" title="Debt instrument description"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zV28fEWOu5ha" title="Debt instrument description">SOFR + 4.92</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">976</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,367</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermLoansFromBank_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zeR5wfZyPMKh" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Long-term loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zcs2tCEsAz63" title="Debt instrument description"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zmpZ59CaxZb5" title="Debt instrument description">SOFR + 4.92</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">976</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,367</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LineOfCredit_iI_pn3n3_hdei--LegalEntityAxis__custom--QuantumXLabsIncMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleLoanJuneFacilityMember_zXsnJsdFU5Ig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Short-term convertible loans – June 2024 Facility Agreement – Quantum X Labs Inc.</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__dei--LegalEntityAxis__custom--QuantumXLabsIncMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleLoanJuneFacilityMember_zUHD0WbrQ4r8" title="Debt instrument description"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__dei--LegalEntityAxis__custom--QuantumXLabsIncMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleLoanJuneFacilityMember_zbRxtks0uQ8" title="Debt instrument description">12</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">667</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">867</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NotesPayableToBankCurrent_iI_pn3n3_hdei--LegalEntityAxis__custom--QuantumXLabsIncMember_zLo0hY5RzTn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Bank loan</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,905</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,494</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> B. Gix Media’s Financing Agreement and short-term loans: On October 13, 2021, Gix Media entered into a financing agreement with Bank Leumi Le Israel Ltd (“Leumi”), an Israeli bank, for the provision of a line of credit in the total amount of up to $<span id="xdx_908_eus-gaap--LineOfCredit_iI_pn3n3_c20211013__dei--LegalEntityAxis__custom--GixMediaMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zoi8UUHFAiUg" title="Line of credit">3,500, which will be determined on a monthly basis at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211013__dei--LegalEntityAxis__custom--GixMediaMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LineOfCreditMember_zxVxrwDGiLtc" title="Debt instrument, interest rate, stated percentage">80% of Gix Media’s accounts receivable balance (the “Gix Media Credit Line”) and a long-term loan totaling $<span id="xdx_90C_eus-gaap--LongTermDebt_iI_pn3n3_c20211013__dei--LegalEntityAxis__custom--GixMediaMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zGjFIxO1SzX9" title="Long term debt">6,000, which Gix Media used to finance the acquisition of Cortex (the “Financing Agreement”) (see note 6.A). On February 4, 2025, Gix Media and Leumi entered into a fifth addendum to the Financing Agreement, which was effective as of January 29, 2025, according to which, inter alia: (i) the Gix Media Credit Line was extended to March 31, 2025; (ii) the repayment the outstanding principal amounts of the long term bank loans of Gix Media under the Financing Agreement, was deferred until the actual deposit by the Company in Gix Media’s account of an investment account equal to the amounts of the deferred long term bank loans owned by Gix Media (the “Investment Amount”), which in any event shall be no later than March 31, 2025 (the “Deposit Date”); (iii) upon such Deposit Date, all deferred payments will be immediately repaid using the deposited amounts and any remaining amounts from any other sources; (iv) all remaining future due payments will be repaid as scheduled until the end of the updated terms of each long term bank loan. On March 30, 2025, Gix Media and Leumi entered into a sixth additional addendum to the Financing Agreement, which extended the Deposit Date until May 20, 2025. On June 18, 2025, Gix Media received a short-term loan of $1,722, bearing an annual interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateTerms_c20250618__20250618__dei--LegalEntityAxis__custom--GixMediaLtdOneMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zilbUHZHd5Gf">SOFR + 4.65%, which was <span id="xdx_908_eus-gaap--DebtInstrumentFrequencyOfFee_c20250618__20250618__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GixMediaLtdOneMember_zHsMUL6XxRth" title="Debt instrument frequency">repaid in a single payment on July 3, 2025. On July 3, 2025, Gix Media received a short-term loan of $<span id="xdx_907_eus-gaap--LoansPayableToBankCurrent_iI_pn3n3_c20250703__dei--LegalEntityAxis__custom--GixMediaLtdOneMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zCccHs9njd67" title="Short-term bank loans">1,948, bearing an annual interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateTerms_c20250703__20250703__dei--LegalEntityAxis__custom--GixMediaLtdOneMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_z9xtI1wTOkM5" title="Debt instrument description">SOFR + 4.65%, which was <span id="xdx_900_eus-gaap--DebtInstrumentFrequencyOfFee_c20250703__20250703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GixMediaLtdOneMember_zTZOrA0x1n6b" title="Debt instrument frequency">repaid in a single payment on August 4, 2025. On July 8, 2025, Gix Media and Leumi entered into an agreement in respect of the Financing Agreement, (the “July 2025 Repayment and Financing Agreement”) according to which, inter alia: (i) the Deposit Date was extended until October 1, 2025 (ii) Gix Media agreed to repay $<span id="xdx_904_ecustom--CurrentMaturitiesOfLongtermLoan_iI_pn5n6_c20250708__dei--LegalEntityAxis__custom--GixMediaAndLeumiMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zGrooFmj9nE3" title="Long term loan maturity">2.4 million to Leumi by October 1, 2025, and (iii) subject to the full repayment of the $<span id="xdx_901_eus-gaap--RepaymentsOfShortTermDebt_pn5n6_c20250708__20250708__dei--LegalEntityAxis__custom--GixMediaAndLeumiMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zWCGb2IGi3vb" title="Repayment of short term debt">2.4 million, Leumi would provide a new loan equal to the then outstanding balance of the debt. The loan will be repaid in up to 24 monthly payments at an annual interest rate of Leumi’s applicable rate at the time of the granting of the loan. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 7: LOANS (Cont.) B. Gix Media’s Financing Agreement and short-term loans: (Cont.) In July 2025, Gix Media repaid a total of $<span id="xdx_903_eus-gaap--RepaymentsOfDebt_pn5n6_c20250701__20250731__us-gaap--TypeOfArrangementAxis__custom--JulyTwoThousandTwentyFiveRepaymentAndFinancingAgreementMember__dei--LegalEntityAxis__custom--GixMediaLtdMember_zJXc0ykbTHll" title="Loan amount repaid">2.4 million to Leumi in accordance with the July 2025 Repayment and Financing Agreement. As a result, the outstanding balance of the existing short-term loan of $<span id="xdx_90E_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20250731__us-gaap--TypeOfArrangementAxis__custom--JulyTwoThousandTwentyFiveRepaymentAndFinancingAgreementMember__dei--LegalEntityAxis__custom--GixMediaLtdMember_zsFZnx4URexd" title="Short-term loan">1,948 and the long-term loans under the Financing Agreement were extinguished on July 10, 2025. On the same date, Gix Media received a new loan in the amount of $<span id="xdx_907_eus-gaap--ProceedsFromLoans_pn3n3_c20250701__20250731__us-gaap--TypeOfArrangementAxis__custom--JulyTwoThousandTwentyFiveRepaymentAndFinancingAgreementMember__dei--LegalEntityAxis__custom--GixMediaLtdMember_zA7H4tHm5V66" title="Loans">1,562 to be repaid in 24 consecutive monthly payments beginning in October 2025, at an annual interest rate of <span id="xdx_905_eus-gaap--DebtInstrumentDescription_c20250701__20250731__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GixMediaLtdMember_zVJkjgHj7f8c" title="Debt instrument description">SOFR + 4.92%. As of June 30, 2026, Gix Media has drawn $262 of the Gix Media Credit Line. C. Long term loan and issuance of warrants: On November 15, 2023, Viewbix Israel entered into a loan agreement with certain lenders, pursuant to which Viewbix Israel received aggregate loans of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231115__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ViewbixIsraelMember_zXjSVkSdiidk" title="Lenders provided loans in the aggregate amount">480 (the “2023 Loan”). In connection with the 2023 Loan, the Company issued to each lender a warrant to purchase shares of common stock (the “2023 Warrants”). The 2023 Warrants are exercisable to <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231115__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentyThreeWarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ViewbixIsraelMember_zuwwDOeJ6b52" title="Warrants excercisable">120,000 shares of common stock, at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231115__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentyThreeWarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ViewbixIsraelMember_zb4kBfGxQxN" title="Excercise price">2.00 per share and will expire on <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20231115__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentyThreeWarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ViewbixIsraelMember_zdfc10HOC3o9" title="Warrants expire date">December 31, 2025. The Company recorded the 2023 Warrants as an equity instrument. The terms of the 2023 Loan were substantially amended on June 18, 2024, by the June 2024 Facility Agreement (see note 7.D). These amendments represented a substantial modification in accordance with ASC Topic 470. Accordingly, the terms modification was accounted for as an extinguishment of the original financial liability and the initial recognition of new financial instruments issued at their fair value as of the effective date of the June 2024 Facility Agreement. On December 31, 2025, all 2023 Warrants were expired. D. June 2024 Facility Agreement: On June 18, 2024, the Company entered into a credit facility agreement with a group of lenders including a lead lender (the “June 2024 Lead Lender”, and collectively, the “June 2024 Lenders”) for an amount of up to $<span id="xdx_90E_eus-gaap--LineOfCredit_iI_pn5n6_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__srt--RangeAxis__srt--MaximumMember_zg34l58aebTj" title="Line of credit">1.0 million which was amended and restated on July 22, 2024 (the “June 2024 Facility Agreement”). The June 2024 Facility Agreement also includes $<span id="xdx_900_eus-gaap--LineOfCreditFacilityAverageOutstandingAmount_pn3n3_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_zGM5XvEKfMk3" title="Line of credit facility, outstanding debt owed">531 of outstanding debt owed by the Company to the lenders of the 2023 Loan (see note 7.C), such that the total amount of the credit line reached $1.53 million (the “Total Credit Facility Amount”). The Total Credit Facility Amount will be due for repayment following <span id="xdx_901_eus-gaap--LineOfCreditFacilityExpirationPeriod_dtM_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_zhAU5bTmF6Kb" title="Line of credit facility, expiration period">12 months from the date of the June 2024 Facility Agreement (the “Initial Maturity Date”) or alternatively, in the event the completion of the Uplist (as defined in note 1.G) prior to the Initial Maturity Date, then the Total Credit Facility Amount will be due for repayment following 12 months from the Uplist Date. The Total Credit Facility Amount will be available for use as follows: <span id="xdx_905_eus-gaap--LineOfCreditFacilityDescription_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_zRvMtij0sFIb" title="Line of credit facility, withdrawn amount description">(a) $350 upon the date of the June 2024 Facility Agreement, (b) $150 upon submitting a prospectus for the registration of shares to be issued to the June 2024 Lenders, and (c) $500 upon the completion of the Uplist. The Total Credit Facility Amount will accrue interest at a rate of <span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_zMvLjdJ9h2Jk" title="Line of credit facility, interest percentage">12% per annum, to be paid in advance. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 7: LOANS (Cont.) D. June 2024 Facility Agreement (Cont.): The interest for the first year of the June 2024 Facility Agreement, which was equal to $184, was paid by the Company in advance in: (a) <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zB36hmsECiMa">183,679 shares of the Company’s common stock, reflecting a value of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9mdrVkRxMAi">1.00 per share for each dollar of interest accrued on the Total Credit Facility Amount, and (b) <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_z6vdWRBSyeEf">183,679 warrants to purchase <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8Zx5AzWBUS2">183,679 shares of the Company’s common stock at an exercise price of $1.00 per share. The warrants will be exercisable for a 3 three-year period from the date of the June 2024 Facility Agreement. Immediately following the effectiveness of the Uplist, $<span id="xdx_905_eus-gaap--LineOfCreditFacilityIncreaseAccruedInterest_pn3n3_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_z1nbxSEMkMaf" title="Credit facility">663 of the Total Credit Facility Amount will be automatically converted into units, which will include shares of common stock at a conversion rate of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_znOTU8j8T3E6" title="Conversion rate">1.00 per share, equal to an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_zwjBPPQJQkrk" title="Number of shares issued">662,957 shares of common stock and the same amount of warrants to purchase common stock of the Company with an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRfX4iDlOyT9">1.00 per share. The warrants will be exercisable for a three-year period from the Uplist Date. During the term of the June 2024 Facility Agreement, some of the June 2024 Lenders whose portion of the Total Credit Facility Amount is not automatically converted as part of the Uplist will have the right to convert their portion of the Total Credit Facility Amount within 12 months from the Uplist Date into units, which will include shares of common stock of the Company at a conversion rate of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_zpASUGXLUiMl" title="Conversion rate">1.00 per share, equal to an aggregate of up to <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember__srt--RangeAxis__srt--MaximumMember_zEi4rwiPquW6" title="Number of shares issued">362,004 shares of common stock and the same amount of warrants to purchase common stock of the Company with an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zt30jxgsh4t" title="Exercise price">1.00 per share. The warrants will be exercisable for a three-year period from the issuance date. In addition, the Company paid to the June 2024 Lead Lender a commission consisting of: (a) <span id="xdx_904_eus-gaap--SharesIssued_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvUsnZXGyNyf" title="Shares issued">50,000 shares of common stock of the Company, (b) <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zn1KzH3yijD1" title="Warrants to purchase">50,000 warrants to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpIhOB8ZpcGk" title="Warrants to purchase">50,000 shares of common stock of the Company at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuVOl7oWVnR4" title="Warrants exercise price">1.00 per share (c) <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZrVAtIICSTd" title="Warrants to purchase">625,000 warrants for the purchase of <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmKlmkfN2qB4" title="Warrants to purchase">625,000 shares of common stock with an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx7f4vvNauc5" title="Warrants exercise price">4.00 per share (“June 2024 Lead Lender Fee Warrants”). The June 2024 Lead Lender Fee Warrants are exercisable for a three-year period from the date of the June 2024 Facility Agreement. The June 2024 Lead Lender Fee Warrants, which were exercisable immediately after the closing of the June 2024 Facility Agreement, were allocated subject to certain ownership restrictions, adjustments, and anti-dilution protections. In July 2024, following the closing of the 2024 Private Placement (as defined in note 10.B), the exercise price of the June 2024 Lead Lender Fee Warrants was adjusted to $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_zo9wb6oxgSnc" title="Exercise price">0.472, which is equal to the effective price per share of common stock in the 2024 Private Placement, and the number of shares of common stock issuable upon the exercise of the June 2024 Lead Lender Fee Warrants was also adjusted to a total of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_zzypaia3por8" title="Number of warrants issued">5,296,610 shares, such that the adjusted exercise price and number of warrants issued is equal to an aggregate amount of $<span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_zSYCuGW48Qo6" title="Warrants exercise amount">2.5 million. The conversion related features of the June 2024 Facility Agreement were bifurcated from their host debt contract and recognized as liabilities measured at fair value at each balance sheet date. Loans received in connection with the June 2024 Facility Agreement were initially recorded at their fair value and subsequently measured at cost. The shares and warrants issued as prepayment of interest and as commission to the June 2024 Lead Lender were initially recognized at fair value and classified in equity. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 7: LOANS (Cont.) D. June 2024 Facility Agreement (Cont.): In connection with the June 2024 Facility Agreement, the Company incurred deferred debt issuance costs of $60, consisting of an annual advance interest payment. The deferred debt issuance costs were recorded in other current assets in the Company’s balance sheet and are amortized as financial expense over the term of the June 2024 Facility Agreement. The June 2024 Lead Lender Fee Warrants were initially recognized in fair value at the amount of $<span id="xdx_90C_ecustom--ClassOfWarrantOrRightExerciseAmountOfWarrants_pn3n3_c20240618__20240618__us-gaap--ClassOfWarrantOrRightAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_zYxPZeUDTHY5" title="Warrants exercise amount">1,833 and classified as a liability measured at fair value at each balance sheet date. Following the closing of the 2024 Private Placement (see note 10.B) and the adjustments made to the number of shares in the June 2024 Lead Lender Fee Warrants as part of the June 2024 Facility Agreement, the June 2024 Lead Lender Fee Warrants were reclassified to equity. On June 5, 2025, upon completion of the Uplist, the Company drew additional $<span id="xdx_901_ecustom--LineOfCreditFacilityAdditionalBorrowingAmount_iI_pn3n3_c20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_z2fwEIF0Trp1" title="Line of credit additional borrowing amount">500 of the Total Credit Facility Amount (the “Additional Amount”). The Additional Amount was provided by the June 2024 Lead Lender, which has the right to convert the Additional Amount within 12 months from the Uplist Date into units, which will include shares of common stock of the Company at a conversion rate of $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_zJsZAey790yf" title="Conversion rate">1.00 per share, equal to an aggregate of up to <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember__srt--RangeAxis__srt--MaximumMember_zXZyEsILQSV8" title="Number of shares issued">500,000 shares of common stock and the same amount of warrants to purchase shares of common stock of the Company with an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCurkDeQocAc" title="Exercise price">1.00 per share. The warrants will be exercisable for a three-year period from the issuance date. The Additional Amount was recorded as a short-term convertible loan. In addition, immediately following the Uplist, $<span id="xdx_907_eus-gaap--LineOfCreditFacilityIncreaseAccruedInterest_pn3n3_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_zLsPmIbE3YU1" title="Credit facility amount">663 of the Total Credit Facility Amount was converted into units, which included <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--JuneTwentyTwentyFourConvertibleStockMember_zO86NcjpFSh5" title="Number of shares issued">662,957 shares of common stock and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zV0itcFXimze" title="Exercise price">1.00 per share for a three-year period from the Uplist Date. The warrants were recorded at fair value and were classified as equity. During June and July 2025, out of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmi4XE3Ht1J2" title="Warrants granted"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250701__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziWebuSFKQtd" title="Warrants granted">896,636 warrants granted under the June 2024 Facility Agreement, <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBuswJQRFSB9" title="Warrants exercised"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250701__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpEqVsa5uH2b" title="Warrants exercised">722,495 warrants were exercised into <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZI9KPyyo0xf" title="Warrants exercised"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250701__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu0mNaPiOWIc" title="Warrants exercised">722,495 shares of common stock. The Company received total proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkOCQgXUr60b" title="Proceeds of exercise the warrants"><span id="xdx_907_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20250701__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXnRDx4QoSFf" title="Proceeds of exercise the warrants">722 upon exercise of the warrants. In June 2026, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSYolV5LJLEk" title="Warrants exercised">2,680,000 of the June 2024 Lead Lender Fee Warrants were exercised into <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziCtfyFcJ7N9" title="Warrants exercised">2,680,000 shares of common stock. The Company received total proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzf1WzwftlIa" title="Proceeds of exercise the warrants">1,265 upon exercise of the warrants (see also note 13.C). In April 2026, the Company repaid $<span id="xdx_904_eus-gaap--PaymentsForRepurchaseOfWarrants_pn3n3_c20260401__20260430__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zffuj6aAR1w8" title=" Repurchase of warrants">200 of the Additional Amount to the June 2024 Lead Lender. In July 2026, $<span id="xdx_903_eus-gaap--LineOfCredit_iI_pn3n3_c20260731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRHfl9yaO6Wk" title="Line of credit">589 of the Total Credit Facility Amount was converted into <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_pid_c20260731__20260731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyhxVJwxyWMl" title="Converted into shares and warrants">588,553 shares and warrants, including the remaining $<span id="xdx_904_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_pn3n3_c20260731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrMKATOHn1j2" title="Line of credit facility, remaining borrowing capacity">300 of the Additional Amount (see also note 13.D). E. First July 2024 Facility Agreement On July 4, 2024, the Company entered into a credit line agreement with a certain lender (the “First July 2024 Facility Agreement”). Under the First July 2024 Facility Agreement and amendments from July 22, 2024, and July 25, 2024, the lender will provide a total credit line of $2.5 million (the “First July 2024 Facility Loan Amount”), which will be available for use as follows: <span id="xdx_900_eus-gaap--LineOfCreditFacilityDescription_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_zpCh1uvmOsI2" title="Line of credit facility, withdrawn amount description">(a) $50 upon the date of the First July 2024 Facility Agreement, (b) $50 upon the Uplist, and (c) after the Uplist, $200 will be available for use on a quarterly basis until the total amount reaches $2.5 million. The First July 2024 Facility Agreement will remain available until the earliest of: (a)(1) full utilization of the First July 2024 Facility Loan Amount, (a)(2) after 36 months from the date of the First July 2024 Facility Agreement, and (b) upon such date that the Company completes a $<span id="xdx_90E_ecustom--LineOfCreditFacilityFinancingTransaction_pn5n6_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_zTGTlgkvbd3b" title="Line of credit facility, financing transaction">2.0 million financing transaction (the “First July 2024 Facility Term”). In the event the First July 2024 Facility Term lapses, the First July 2024 Facility Loan Amount will be repaid to the lender immediately (see note 10.C). QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 7: LOANS (Cont.) E. First July 2024 Facility Agreement (Cont.) The First July 2024 Facility Agreement Amount accrued interest at a rate of <span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_zu4Fy0lRpuni">12% per annum. The interest for the first year was paid in advance in: (a) <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsdBSPzUA82j">300,000 shares of the Company’s common stock at a conversion rate of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zz0Pw17Ysx9e">1.00 for each dollar of interest accrued on the total amount, and (b) <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_zBgmnI8U0hGd">300,000 warrants to purchase 300,000 shares of the Company’s common stock an exercise price of $1.00 per share. The warrants are exercisable upon issuance at an exercise price of $1.00 per share of common stock and will be exercisable for a <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pid_dtY_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_zu6MLKJqdtHe" style="display: none">3 three-year period from the date of the First July 2024 Facility Agreement. Immediately after the Uplist, $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstJulyTwentyTwentyFourConvertibleStockMember_zkgplxc6VyRa" title="Lenders provided loans in the aggregate amount">100 from the First July 2024 Facility Loan Amount will be automatically converted into common stock of the Company at an exercise price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstJulyTwentyTwentyFourConvertibleStockMember_zJdj6u7rKmba" title="Conversion price">1.00 per share. Additionally, the Company will issue an identical number of warrants to purchase common stock of the Company at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstJulyTwentyTwentyFourConvertibleStockMember_z4Vm1r3Cfgf9" title="Exercise price">1.00 per share. Furthermore, the Company paid the lender of the First July 2024 Facility Agreement a one-time fee consisting of: (a) <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_zfhUmnjHQoE3">125,000 shares of common stock of the Company, which representing a fee of five percent (<span id="xdx_906_ecustom--LineOfCreditFacilityOneTimeFeePercentage_pid_dp_uPure_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_ztOaVk6UCI8l">5%) of the First July 2024 Facility Loan Amount, at a share price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_zx98ziv96gh6">1.00 per share, and (b) <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_zU2WXjk66ql6">250,000 warrants to purchase <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjbrcLcfRhUi">250,000 shares of common stock of the Company at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_zPRlCxW5YJwd">1.00 per share. The warrants are exercisable for three years <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pid_dtY_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_za7Myk9yfif8" style="display: none">3 from the date of the First July 2024 Facility Agreement. The conversion related features of the First July 2024 Facility Agreement were bifurcated from their host debt contract and recognized as liabilities measured at fair value at each balance sheet date. In connection with the First July 2024 Facility Agreement, the Company incurred deferred debt issuance costs of $<span id="xdx_900_ecustom--DeferredFinanceCostsNetIncludingUpfrontFee_iI_pn3n3_c20240731__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_zw6qxjUIDnE9" title="Deferred debt issuance costs">375, which consisted of a one-time fee to the lender of the First July 2024 Facility Agreement, an annual advance interest payment and other additional direct costs. The deferred debt issuance costs were recorded in other current assets in the Company’s balance sheet and were amortized as financial expense over the term of the First July 2024 Facility Agreement. Deferred debt issuance costs amounted to $<span id="xdx_90E_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20241231__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_zzKntRMYdq2f" title="Deferred debt issuance costs">315 as of December 31, 2024, and were fully amortized during year ended December 31, 2025, following the termination of the First July 2024 Facility Agreement (see note 10.C). Under the terms of the First July 2024 Facility Agreement, the Company received in July 2024 a loan of $<span id="xdx_903_ecustom--ProceedsFromLoansReceived_pn3n3_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--FirstJulyTwentyTwentyFourLendersMember_z83KMK0oIw7c" title="Received loan">50 and on the Uplist Date the Company drew additional $<span id="xdx_909_ecustom--LineOfCreditFacilityAdditionalBorrowingAmount_iI_pn3n3_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember_zMo6PvuRo7F" title="Line of credit additional borrowing amount">50 of the First July 2024 Facility Loan Amount. These loans were recorded as short-term convertible loans and their fair value was substantially the same as the amount received. In addition, On the Uplist Date, $100 of the First July 2024 Facility Loan Amount was converted into units, which included <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240704__20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqscIIjueXr2" title="Number of shares new isues">100,000 shares of common stock and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240704__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstJulyTwentyTwentyFourConvertibleStockMember_ztlib0aZcfi5" title="Exercise price">1.00 per share for a three-year period from the Uplist Date. The warrants were recorded at fair value and were classified as equity. During June 2025, all <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zU7izn3z0wLe" title="Warrants granted">650,000 warrants granted under the First July 2024 Facility Agreement were exercised into <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPcne3XRiIIl" title="Warrants exercised">650,000 shares of common stock. The Company received total proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zO7ocGXf5tv4" title="Proceeds from warrant exercises">650 upon exercise of the warrants. On July 14, 2025, following the closing of the July 2025 Private Placement and the proceeds received by the Company (see note 10.C), the First July 2024 Facility Agreement was terminated. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 7: LOANS (Cont.) F. Second July 2024 Facility Agreement On July 28, 2024, the Company entered into a credit line agreement with certain lenders (the “Second July 2024 Facility Agreement”) for a total amount of $3.0 million (the “Second July 2024 Facility Loan Amount”). The Second July 2024 Facility Loan Amount will remain available until the earliest of: (a) (1) full utilization of the Second July 2024 Facility Loan Amount, (a)(2) after 40 months from the date of Second July 2024 Facility Agreement, and (b) upon such date that the Company completes a $<span id="xdx_904_ecustom--LineOfCreditFacilityFinancingTransaction_pn5n6_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_zrGHDIrtWCqf" title="Line of credit facility, financing transaction">2.5 million financing transaction. The Second July 2024 Facility Loan Amount accrued interest at a rate of <span id="xdx_90F_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_zhRswn0mJSF1" title="Accrued interest percentage">12% per annum. The interest for the first year was paid in advance in: (a) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z28lea9Lxo1e" title="Number of shares issued">360,000 shares of the Company’s common stock, reflecting a share price of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0NhwRnONzR1" title="Conversion price">1.00 per share for each dollar of interest accrued on the total amount, and (b) <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_zN0IhgN3Fae5" title="Warrants to purchase shares">360,000 warrants to purchase <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_z8tFck5FZe9e" title="Number of shares new issues">360,000 shares of common stock of the Company at an exercise price of $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_zM0QgwotA1Gf" title="Conversion price">1.00 per share. The warrants are exercisable for <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pid_dc_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_zcP26QbmDchg" title="Warrants term">three years from the date of the Second July 2024 Facility Agreement. Starting from the second year of the Second July 2024 Facility Agreement, the interest will be paid in cash to the lenders. Immediately after the Uplist, $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondJulyTwentyTwentyFourConvertibleStockMember_zD5uHp8lHpg" title="Lenders provided loans in the aggregate amount">160 out of the Second July 2024 Facility Loan Amount will be automatically converted into common stock of the Company at an exercise price of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondJulyTwentyTwentyFourConvertibleStockMember_zTRs3F5l0wh8" title="Conversion price">1.00 per share. Additionally, the Company will issue an identical number of warrants to purchase common stock of the Company at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondJulyTwentyTwentyFourConvertibleStockMember_zbSQFSfQy8y4" title="Exercise price">1.00 per share. Furthermore, the Company paid the lenders of the Second July 2024 Facility Agreement a one-time fee consisting of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SecondJulyTwentyTwentyFourLendersMember_z5vtr39kNOEc" title="Number of shares issued">150,000 shares of common stock of the Company, which represents a fee of five percent (<span id="xdx_906_ecustom--LineOfCreditFacilityOneTimeFeePercentage_pid_dp_uPure_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SecondJulyTwentyTwentyFourLendersMember_zgFrM29EDKwc" title="Line of credit facility, one-time fee, percentage">5%) of the Second July 2024 Facility Loan Amount at a share price of $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SecondJulyTwentyTwentyFourLendersMember_ztYrgs6Yfvlc" title="Conversion price">1.00 per share. The conversion related features of the Second July 2024 Facility Agreement were bifurcated from their host debt contract and recognized as liabilities measured at fair value at each balance sheet date. In connection with the Second July 2024 Facility Agreement, the Company incurred deferred debt issuance costs of $<span id="xdx_904_eus-gaap--DeferredFinanceCostsCurrentGross_iI_pn3n3_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SecondJulyTwentyTwentyFourLendersMember_zL05MCHqg7L4" title="Deferred debt issuance costs">355, which consisted of a one-time fee to the lenders of the Second July 2024 Facility Agreement, an annual advance interest payment and other additional direct costs. The deferred debt issuance costs were recorded in other current assets in the Company’s balance sheet and were amortized as financial expense over the term of the Second July 2024 Facility Agreement. Deferred debt issuance costs amounted to $<span id="xdx_906_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SecondJulyTwentyTwentyFourLendersMember_ziSxCxb13l7e" title="Deferred debt issuance costs">302 as of December 31, 2024, and were fully amortized during the year ended December 31, 2025, following the termination of the Second July 2024 Facility Agreement (see note 10.C). QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 7: LOANS (Cont.) F. Second July 2024 Facility Agreement (Cont.) Under the terms of the Second July 2024 Facility Agreement, the Company received in July 2024 a loan of $<span id="xdx_907_ecustom--ProceedsFromLoansReceived_pn3n3_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SecondJulyTwentyTwentyFourLendersMember_zDmu9583sLEk" title="Received loan">80 and on the Uplist Date the Company drew additional $<span id="xdx_906_ecustom--LineOfCreditFacilityAdditionalBorrowingAmount_iI_pn3n3_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember_zUbdp6XJiHoh" title="Line of credit additional borrowing amount">80 of the Second July 2024 Facility Loan Amount. These loans were recorded as short-term convertible loans and their fair value was substantially the same as the amount received. In addition, On the Uplist Date, $160 of the Second July 2024 Facility Loan Amount was converted into units, which included <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240728__20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1tgS2hQxc04" title="Number of shares new isues">160,000 shares of common stock and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240728__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondJulyTwentyTwentyFourConvertibleStockMember_zmeKbfJPvzWe" title="Exercise price">1.00 per share for a three-year period from the Uplist Date. The warrants were recorded at fair value and were classified as equity. During June 2025, all <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zai857SdBK3k" title="Warrants granted">520,000 warrants granted under the Second July 2024 Facility Agreement were exercised into <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVIPCTVffxCd" title="Warrants exercised">520,000 shares of common stock. The Company received total proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLy8R21z6LKc" title="Proceeds from warrant exercises">520 upon exercise of the warrants. On July 14, 2025, following the closing of the July 2025 Private Placement and the proceeds received by the Company (see note 10.C), the Second July 2024 Facility Agreement was terminated.

The following is the composition of the balance of the Group’s loans according to their nominal value: SCHEDULE OF COMPOSITION OF BALANCE OF GROUP’S LOANS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest rate</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260630_zQX5PGDpkUI3" style="border-bottom: Black 1pt solid; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20251231_zqeyoTaTHPM1" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--LoansPayableToBankCurrent_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zMp1M9fo9VKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Short-term bank loans – Gix Media</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_ztmQcb0EqN1f" title="Debt instrument description"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zvnobnfMffci" title="Debt instrument description">SOFR + 4.95</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">260</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LoansPayableToBankCurrent_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zTIpPEiCzeac" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Short-term bank loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_zpTiGAh39QV6" title="Debt instrument description"><span id="xdx_900_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--DebtInstrumentAxis__custom--ShortTermBankLoanMember_ziaIUyFHGWWk" title="Debt instrument description">SOFR + 4.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">260</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermLoansFromBank_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zYd4FBIZYaNb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Long-term bank loan, including current maturity – Gix Media (received on July 10, 2025)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_ztx0tGMnDqme" title="Debt instrument description"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zV28fEWOu5ha" title="Debt instrument description">SOFR + 4.92</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">976</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,367</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermLoansFromBank_iI_pn3n3_hdei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zeR5wfZyPMKh" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Long-term loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateTerms_c20260101__20260630__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zcs2tCEsAz63" title="Debt instrument description"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateTerms_c20250101__20251231__dei--LegalEntityAxis__custom--GixMediaLtdMember__us-gaap--AwardDateAxis__custom--JulyTenTwoThousandTwentyFiveMember_zmpZ59CaxZb5" title="Debt instrument description">SOFR + 4.92</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">976</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,367</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LineOfCredit_iI_pn3n3_hdei--LegalEntityAxis__custom--QuantumXLabsIncMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleLoanJuneFacilityMember_zXsnJsdFU5Ig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Short-term convertible loans – June 2024 Facility Agreement – Quantum X Labs Inc.</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__dei--LegalEntityAxis__custom--QuantumXLabsIncMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleLoanJuneFacilityMember_zUHD0WbrQ4r8" title="Debt instrument description"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__dei--LegalEntityAxis__custom--QuantumXLabsIncMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleLoanJuneFacilityMember_zbRxtks0uQ8" title="Debt instrument description">12</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">667</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">867</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NotesPayableToBankCurrent_iI_pn3n3_hdei--LegalEntityAxis__custom--QuantumXLabsIncMember_zLo0hY5RzTn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Bank loan</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,905</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,494</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

SOFR + 4.95

262000

260000

SOFR + 4.95

262000

260000

SOFR + 4.92

976000

1367000

SOFR + 4.92

976000

1367000

0.12

667000

867000

1905000

2494000

3500000

0.80

6000000

1722000

SOFR + 4.65%

repaid in a single payment on July 3, 2025.

1948000

SOFR + 4.65%

repaid in a single payment on August 4, 2025.

2400000

1948000

1562000

SOFR + 4.92%

262000

480000

120000

2.00

2025-12-31

1000000.0

531000

1530000

P12M

(a) $350 upon the date of the June 2024 Facility Agreement, (b) $150 upon submitting a prospectus for the registration of shares to be issued to the June 2024 Lenders, and (c) $500 upon the completion of the Uplist.

0.12

184000

183679

1.00

183679

1.00

P3Y

663000

1.00

662957

1.00

362004

1.00

50000

1.00

625000

4.00

0.472

5296610

2500000

60000

1833000 500000

1.00

500000

1.00

663000

662957

1.00

896636

722495

722000

2680000

1265000

200000

589000

588553

300000

2500000

(a) $50 upon the date of the First July 2024 Facility Agreement, (b) $50 upon the Uplist, and (c) after the Uplist, $200 will be available for use on a quarterly basis until the total amount reaches $2.5 million.

2500000

2000000.0

0.12

300000

1.00

300000

1.00

P3Y

100000

1.00

125000

0.05

1.00

250000

1.00

P3Y

375000

315000

50000 50000

100000

1.00

650000

3000000.0

2500000

0.12

360000

1.00

360000

1.00

P3Y

160000

1.00

150000

0.05

1.00

355000

302000

80000 80000

160000

1.00

520000

NOTE 8: FINANCIAL INSTRUMENTS AT FAIR VALUE Financial instruments: The Company has level 3 financial instruments that were recognized at fair value upon initial recognition of each financial instrument and subsequently measured at fair value at each balance sheet date, consisting of: (i) the earn-out liability arising from the Metagramm Acquisition (see note 6.B); and (ii) embedded derivatives arising from the June 2024 Facility Agreement, the First July 2024 Facility Agreement and the Second July 2024 Facility Agreement (see notes 7.D, 7.E, 7.F). On June 5, 2025, following the Uplist, the Company converted all embedded derivatives into equity. Prior to the conversion, and as of the Uplist Date, these embedded derivatives were measured at their intrinsic value through profit or loss. <p id="xdx_89B_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zitu31rJ7jia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The following table presents the financial instruments that were measured at fair value through profit or loss: SCHEDULE OF FINANCIAL INSTRUMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--EarnoutLiabilityMember_z4JUUQ5Va4Qk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Earn-out liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iS_pn3n3_zgEbInJECHP" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold">Balance as of January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">793</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--EarnoutLiabilityRecordedInConnectionWithMetagrammAcquisition_pn3n3_zPH4py3nAizh" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Earn-out liability recorded in connection with Metagramm Acquisition (see note 6.B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_pn3n3_di_zOWoMgKp08sl" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Net changes at fair value recognized through profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_iN_pn3n3_di_zoGWIGl3vNkd" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Embedded derivatives converted to equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--EarnoutPayableAmountsUponAchievingFinancingMilestoneInConnectionWithMetagrammAcquisition_pn3n3_zrcZmgvQ8qbd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Earn-out payable amounts upon achieving financing milestone in connection with Metagramm Acquisition (see notes 6.B, 10.D)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(67</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iE_pn3n3_zlI3u8o51VO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">726</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zDEE04kYs51a" style="border-bottom: Black 1pt solid; text-align: center">Embedded derivatives</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--EarnoutLiabilityMember_zBg5Y5O6Bt33" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Earn-out liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iS_pn3n3_z1zfYtiRT0g8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold">Balance as of January 1, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">29</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iS_pn3n3_zQxrN4Ck5dmi" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Beginning balance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--EarnoutLiabilityRecordedInConnectionWithMetagrammAcquisition_pn3n3_zV5pDX0USg59" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Earn-out liability recorded in connection with Metagramm Acquisition (see note 6.B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,010</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--EarnoutPayableAmountsUponAchievingFinancingMilestoneInConnectionWithMetagrammAcquisition_pn3n3_zqjyGpUecIng" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Earn-out payable amounts upon achieving financing milestone in connection with Metagramm Acquisition (see note 6.B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(201</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_pn3n3_di_zUfshJiqyUV2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net changes at fair value recognized through profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,121</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_iN_pn3n3_di_zYxc6iKxM0U9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Embedded derivatives converted to equity</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iE_pn3n3_zlyHn1kWpfOc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iE_pn3n3_zgGprS8Zdsn1" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data)

<p id="xdx_89B_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zitu31rJ7jia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The following table presents the financial instruments that were measured at fair value through profit or loss: SCHEDULE OF FINANCIAL INSTRUMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--EarnoutLiabilityMember_z4JUUQ5Va4Qk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Earn-out liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iS_pn3n3_zgEbInJECHP" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold">Balance as of January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">793</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--EarnoutLiabilityRecordedInConnectionWithMetagrammAcquisition_pn3n3_zPH4py3nAizh" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Earn-out liability recorded in connection with Metagramm Acquisition (see note 6.B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_pn3n3_di_zOWoMgKp08sl" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Net changes at fair value recognized through profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_iN_pn3n3_di_zoGWIGl3vNkd" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Embedded derivatives converted to equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--EarnoutPayableAmountsUponAchievingFinancingMilestoneInConnectionWithMetagrammAcquisition_pn3n3_zrcZmgvQ8qbd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Earn-out payable amounts upon achieving financing milestone in connection with Metagramm Acquisition (see notes 6.B, 10.D)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(67</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iE_pn3n3_zlI3u8o51VO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">726</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zDEE04kYs51a" style="border-bottom: Black 1pt solid; text-align: center">Embedded derivatives</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--EarnoutLiabilityMember_zBg5Y5O6Bt33" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Earn-out liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iS_pn3n3_z1zfYtiRT0g8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold">Balance as of January 1, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">29</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iS_pn3n3_zQxrN4Ck5dmi" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Beginning balance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--EarnoutLiabilityRecordedInConnectionWithMetagrammAcquisition_pn3n3_zV5pDX0USg59" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Earn-out liability recorded in connection with Metagramm Acquisition (see note 6.B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,010</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--EarnoutPayableAmountsUponAchievingFinancingMilestoneInConnectionWithMetagrammAcquisition_pn3n3_zqjyGpUecIng" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Earn-out payable amounts upon achieving financing milestone in connection with Metagramm Acquisition (see note 6.B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(201</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_pn3n3_di_zUfshJiqyUV2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net changes at fair value recognized through profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,121</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_iN_pn3n3_di_zYxc6iKxM0U9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Embedded derivatives converted to equity</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iE_pn3n3_zlyHn1kWpfOc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iE_pn3n3_zgGprS8Zdsn1" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

793000

-67000

726000

29000

1010000 -201000

-10121000

16000

10150000

793000

NOTE 9: COMMITMENTS AND CONTINGENCIES Liens: On September 19, 2022, as part of the Reorganization Transaction terms, the Company has provided several liens under Gix Media’s Financing Agreement with Leumi in connection with the Cortex Transaction, as follows: (1) a guarantee to Leumi of all of Gix Media’s obligations and undertakings to Leumi unlimited in amount; (2) a subordination letter signed by the Company to Leumi; (3) A first ranking all asset charge over all of the assets of the Company; and (4) a Deposit Account Control Agreement over the Company’s bank accounts. In connection with the Cortex Transaction, Gix Media has provided several liens under the Financing Agreement with Leumi, as follows: (1) a floating lien on Gix Media’s assets; (2) a lien on Gix Media’s bank account in Leumi; (3) a lien on Gix Media’s rights under the Cortex Transaction; (4) a fixed lien on Gix Media’s intellectual property; and (5) a lien on Gix Media’s full holdings in Cortex. On November 9, 2025, under the Cortex Sale Agreement (see note 6.A), Gix Media provided Leumi a lien on the consideration received in the form of shares and Leumi released its lien on the shares of Cortex sold by Gix Media. Gix Media and Quantum Israel’s restricted deposits, in the amounts of $23 and $25, respectively, as of June 30, 2026, are held as security in respect of credit cards and rented offices.

23000

25000

NOTE 10: SHAREHOLDERS’ EQUITY A. Shares of Common Stock: Shares of Common Stock confer the rights to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds from the Company and will not confer other privileges. On March 24, 2025, the Company entered into the 2025 SEA with Metagramm and all of the shareholders of Metagramm, pursuant to which the Company issued to Metagramm’s shareholders <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250324__20250324__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zKqgOrT5ZDB6" title="Number of stock issued">1,323,000 of the Company’s shares representing <span id="xdx_903_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20250324__20250324__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember__srt--RangeAxis__srt--MaximumMember_zH6rr1Bke2Ol" title="Issued and outstanding share capital, percentage">19.99% of its issued and outstanding share capital in exchange for <span id="xdx_903_ecustom--IssuedAndOutstandingShareCapitalPercentage_pid_dp_uPure_c20250324__20250324__us-gaap--TypeOfArrangementAxis__custom--SecuritiesExchangeAgreementMember_zfnnh6DPmm9g" title="Issued and outstanding share capital, percentage">100% of Metagramm’s issued and outstanding share capital (see note 6.B). On June 5, 2025, following the Uplist and as part of the June 2024 Facility Agreement, $<span id="xdx_901_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementMember_zukwd1ZFyvqj" title="Credit facility amount converted">663 of the Total Credit Facility Amount was converted into an aggregate of <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementMember_zgsyRsip4nO8" title="Common stock issued upon conversion">662,957 shares of common stock of the Company and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250605__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementMember_ze2pVVxzIXde" title="Warrant exercise price">1.00 per share. In addition, during June and July 2025, out of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250601__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6Y1tNgjQ14j" title="Warrants granted">896,636 warrants granted under the June 2024 Facility Agreement, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWMYImQ7ETWd" title="Warrants exercised">722,495 warrants were exercised into <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250731__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQpMQ11GVKtg" title="Warrants exercised">722,495 shares of common stock (see note 7.D). On June 5, 2025, following the Uplist and as part of the First July 2024 Facility Agreement, $<span id="xdx_90C_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwoThousandTwentyFourFacilityAgreementMember_zkXrmAf6hwS1" title="Credit facility amount converted">100 of the First July 2024 Facility Loan Amount was converted into an aggregate of <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwoThousandTwentyFourFacilityAgreementMember_zVqLWtqtzH4c" title="Common stock issued upon conversion">100,000 shares of common stock of the Company and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250605__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwoThousandTwentyFourFacilityAgreementMember_zGeiJYeMEWUi" title="Warrant exercise price">1.00 per share. In addition, during June 2025, all <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwoThousandTwentyFourFacilityAgreementMember_zp1uMLiuxDLi" title="Warrants exercised">650,000 warrants granted under the First July 2024 Facility Agreement were exercised into <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--FirstJulyTwoThousandTwentyFourFacilityAgreementMember_zFeFkHajVyef" title="Warrants granted">650,000 shares of common stock (see note 7.E). QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 10: SHAREHOLDERS’ EQUITY (Cont.) A. Shares of Common Stock: (Cont.) On June 5, 2025, following the Uplist and as part of the Second July 2024 Facility Agreement, $<span id="xdx_90B_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwoThousandTwentyFourFacilityAgreementMember_zlG6a4YiaYpd" title="Credit facility amount converted">160 of the Second July 2024 Facility Loan Amount was converted into an aggregate of <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20250605__20250605__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwoThousandTwentyFourFacilityAgreementMember_z2SJ1Viagvpl" title="Common stock issued upon conversion">160,000 shares of common stock of the Company and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250605__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwoThousandTwentyFourFacilityAgreementMember_z49QP8M7Ytgc" title="Warrant exercise price">1.00 per share. In addition, during June 2025, all <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwoThousandTwentyFourFacilityAgreementMember_zSYdMxkCB52g" title="Warrants exercised">520,000 warrants granted under the Second July 2024 Facility Agreement were exercised into <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250601__20250630__us-gaap--TypeOfArrangementAxis__custom--SecondJulyTwoThousandTwentyFourFacilityAgreementMember_zAJ532FGuWrk" title="Warrants granted">520,000 shares of common stock (see note 7.F). On June 15, 2025, the Company issued 37,500 shares of common stock to a consultant as consideration for services provided in connection with the Uplist. The Company recognized $75 of share-based compensation expense, recorded in other expenses, net, during the year ended December 31, 2025. In June 2026, out of <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourFacilityAgreementMember_zmqJnJKfPyb4" title="Warrants granted">5,296,610 warrants granted under the June 2024 Facility Agreement to the June 2024 Lead Lender (see note 7.D), <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFpnSzriJ398" title="Warrants exercised">2,680,000 warrants were exercised into <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKbUZkDRqnXl" title="Warrants exercised">2,680,000 shares of common stock. The Company received total proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPEXOU3urjub" title="Proceeds of exercise the warrants">1,265 upon exercise of the warrants. B. 2024 Private Placement On July 3, 2024, the Company entered into a definitive securities purchase agreement with a certain investor (the “Lead Investor”) for the purchase and sale in a private placement (the “2024 Private Placement”) of units consisting of (i) 256,875 shares of the Company’s common stock at a purchase price of $1.00 per share and (ii) 385,332 warrants to purchase 385,332 shares of the Company’s common stock (the “PIPE Warrants”) to the Lead Investor and other investors acceptable to the Lead Investor and the Company. The PIPE Warrants are exercisable upon issuance at an exercise price of $1.00 per share and have a 3 three-year term from the issuance date. Upon the closing of the 2024 Private Placement, the Company paid the Lead Investor: (1) $<span id="xdx_908_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20240703__20240703__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zFkWinoggroi" title="Actual and documented fees">10 for actual and documented fees and expenses incurred and, (2) a commission consisting of (i) a cash fee of $<span id="xdx_909_eus-gaap--OtherExpenses_pn3n3_c20240703__20240703__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z3LbNSaRcin5" title="Cash fee">13 and (ii) <span id="xdx_906_eus-gaap--SharesIssued_iI_pid_c20240703__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zUltZMgXnBC4" title="Number of shares issued">12,844 shares of the Company’s common stock. The aggregate gross proceeds received by the Company from the 2024 Private Placement were $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20240703__20240703__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNBfxw6UEtmf" title="Proceeds from private placement">257. Following the Uplist Date, out of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240703__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z2Ynklg1bWkc" title="Warrants to purchase common stock">385,332 warrants granted under the 2024 Private Placement, <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250701__20250731__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIFip1HnQbwi" title="Warrants exercised">328,142 warrants were exercised during June and July 2025 into <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250701__20250731__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--CommonStockMember_zbYh8lv0FJKf" title="Warrants exercised">328,142 shares of common stock. The Company received total proceeds of $328 upon exercise of the warrants. C. July 2025 Private Placement On July 11, 2025, the Company entered into a securities purchase agreement with certain accredited investors pursuant to which the Company issued and sold in a private placement, (the “July 2025 Private Placement”) an aggregate of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250711__20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3MBRZD2pZAg" title="Number of shares issued">848,763 shares of common stock, pre-funded warrants to purchase up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zMs0rvgoje54" title="Warrants to purchase common stock">77,160 shares of common stock and common warrants to purchase up to an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPLOGh8aeY6k" title="Warrants to purchase common stock">925,923 shares of common stock, at an offering price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zdv1Ss91NQ1h" title="Offering price per share">4.86 per share of common stock and associated common warrant and an offering price of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znySGwcw92t5" title="Offering price per share">4.8599 per pre-funded warrant and associated common warrant. The pre-funded warrants were immediately exercisable upon issuance at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zTrIrKHrDFU5" title="Warrant exercise price">0.0001 per share and will not expire until exercised in full. The common warrants were immediately exercisable upon issuance at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfSq2iS54MNi" title="Warrant exercise price">4.74 per share, subject to adjustment as set forth therein, and will expire five and a half years from the issuance date. The common warrants may be exercised on a cashless basis if there is no effective registration statement registering the shares of common stock underlying the common warrants. In connection with the July 2025 Private Placement, the Company also entered into a letter agreement with a placement agent on July 11, 2025, according to which the Company paid a cash placement fee equal to <span id="xdx_902_ecustom--CashPlacementFeePercentage_pid_dp_c20250711__20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcO68xHhdJka" title="Cash placement fee percentage">7.0% of the gross proceeds and $50 for reasonable legal fees and disbursements. The July 2025 Private Placement closed on July 14, 2025. The aggregate gross proceeds received by the Company on the closing date were $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20250714__20250714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWViduFd42R7" title="Gross proceeds from private placement">4,500. The Company incurred share issuance costs of $<span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20240714__20240714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4JHYUmnmg51" title="Issuance costs">477 which were recognized as a reduction of additional paid-in capital. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 10: SHAREHOLDERS’ EQUITY (Cont.) C. July 2025 Private Placement (Cont.) In connection with the closing of the July 2025 Private Placement and the related proceeds, the First July 2024 Facility Agreement and the Second July 2024 Facility Agreement were terminated. In addition, the shareholders of Metagramm became entitled to partial earn-out payments on a pro rata basis pursuant to the 2025 SEA (see note 6.B). On September 5, 2025, 20,576 pre-funded warrants were exercised into 20,576 shares of common stock. In June 2026, <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JulyTwentyTwentyFivePrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTvacjkMqUq6" title="Warrants exercised">77,576 common warrants were exercised into <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JulyTwentyTwentyFivePrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHfRKVdi0fub" title="Warrants exercised">77,576 shares of common stock. The Company received total proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--JulyTwentyTwentyFivePrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zW67rYHWLtA1" title="Proceeds of exercise the warrants">368 upon exercise of the warrants. D. 2026 Private Placement On January 1, 2026, the Company entered into an amended and restated securities purchase agreement with certain accredited investors pursuant to which the Company agreed to sell and issue in a private placement, an aggregate amount of <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260101__20260101__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbl7Egwkorwe" title="Number of shares issued">800,000 shares of common stock (the “2026 Private Placement”) and common warrants to purchase up to an aggregate amount of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zkHD4XFiKA2" title="Number of warrants issued">640,000 shares of common stock (the “2026 PIPE Warrants”), at an offering price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20260101__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_znicCo6CRm03" title="Offering price per share">1.75 per share of common stock and associated common warrant. The 2026 PIPE Warrants are exercisable upon issuance at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2k6px0LXqs9" title="Exercise price">2.625 per share and will expire <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pid_dc_c20260101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z3l1nDvHjpDh" title="Exercise price">five years from the issuance date. In connection with the 2026 Private Placement, the Company also entered into an advisory agreement, as amended, with L.I.A. Pure Capital Ltd. (“the Advisor”) pursuant to which the Company agreed to pay the Advisor a commission consisting of (i) a cash fee of $70 (the “Fee”) and (ii) a warrant to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20260101__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_ztGTN9nR4svj" title="Warrant purchase">32,000 shares of the Company’s common stock on the same terms as the 2026 PIPE Warrants. Payment of the commission is conditioned upon the closing of the 2026 Private Placement. In addition, in connection with the closing of the 2026 Private Placement, the Company agreed to repay $200 of the outstanding loan amount owed to the Advisor (the “Loan Repayment”) pursuant to the June 2024 Facility Agreement (see note 7.D). The 2026 Private Placement closed on March 4, 2026, pursuant to which the Company issued <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260304__20260304__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandTwentySixPrivatePlacementMember_zq23lz4dbDWa" title="Number of shares issued">800,000 shares of its common stock and warrants to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260304__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandTwentySixPrivatePlacementMember_zzLfIt1g1tB8" title="Number of warrants issued">672,000 shares of its common stock. The aggregate gross proceeds received by the Company were $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20260304__20260304__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandTwentySixPrivatePlacementMember_zzHC6vV5Mzrh" title="Gross proceeds">1,400. The Company incurred issuance costs of $<span id="xdx_90A_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20260304__20260304__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandTwentySixPrivatePlacementMember_zX9pWvBXh0ea" title="Issuance costs">70 which were recognized as a reduction of additional paid-in capital. In connection with the closing of the 2026 Private Placement and the related proceeds, the shareholders of Metagramm became entitled to partial earn-out payments on a pro rata basis pursuant to the 2025 SEA (see note 6.B). In April 2026, the Company paid the Advisor the Fee and repaid the Loan Repayment. In June 2026, out of <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentySixPrivatePlacementMember_z5ij97907tcd" title="Warrants granted">672,000 warrants granted under the 2026 Private Placement, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentySixPrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6CXV4fp3vs4" title="Warrants exercised">297,143 warrants were exercised into <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentySixPrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zP6pUVjoGF2e" title="Warrants exercised">297,143 shares of common stock. The Company received total proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20260601__20260630__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentySixPrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWfakqhdul66" title="Proceeds of exercise the warrants">780 upon exercise of the warrants (see also note 13.B). E. Quantum Israel Acquisition On March 4, 2026, pursuant to the Quantum Israel Acquisition (see not 6.C), the Company issued to the Quantum Israel Shareholders <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260304__20260304__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwIews2spJ7g" title="Number of shares issued">1,866,000 shares of its common stock and pre-funded warrants to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260304__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_zEqe3bk0JcH6" title="Number of warrants issued">4,447,595 shares of its common stock. The pre-funded warrants were exercisable upon issuance at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260304__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_zZOvc5LDJ9z6" title="Exercise price">0.0001 per share and will not expire until exercised in full. In June 2026, <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_zq9xVP0nVzbg" title="Number of shares issued">2,438,088 pre-funded warrants were exercised into <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260601__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--QuantumXLabsLtdMember_zaoKTRQl52Ej" title="Warrants exercised">2,438,087 shares of common stock. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 10: SHAREHOLDERS’ EQUITY (Cont.) F. Warrants: The following table summarizes information of outstanding warrants as of June 30, 2026: SCHEDULE OF OUTSTANDING WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Term</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 32%; text-align: left">Class J Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zk8sJ074APti" style="width: 12%; text-align: right" title="Warrants">32,584</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 18%; text-align: right">July 2029</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zAGLTDkBFE8f" style="width: 12%; text-align: right" title="Warrants">53.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zBAN1F3rQi97" style="width: 12%; text-align: right" title="Exercisable">32,584</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class K Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zIW5EftzflI5" style="text-align: right" title="Warrants">32,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right">July 2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxKm1NXv9T1l" style="text-align: right" title="Warrants">89.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zlucH2amA6Gk" style="text-align: right" title="Exercisable">32,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">June 2024 Facility Agreement Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_zEm9jkQRhST8" style="text-align: right" title="Warrants">174,141</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_900_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_zYsueRkduIA2" title="Warrant Term">June 2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_znLEksYNwHya" style="text-align: right" title="Warrants">1.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_zOwrQYdLOZxd" style="text-align: right" title="Exercisable">174,141</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">June 2024 Lead Lender Fee Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_z2EOF6QIsBHg" style="text-align: right" title="Warrants">2,616,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right">June 2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_z5mVtVnGfoBe" style="text-align: right" title="Warrants">0.472</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_zILdP09WdsVl" style="text-align: right" title="Exercisable">2,616,610</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024 PIPE Warrants (note 10.B)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember_zbXhCFtuCIO4" style="text-align: right" title="Warrants">57,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right">July 2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember_zaEDC6Cix4i2" style="text-align: right" title="Warrants">1.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember_zwJBckp8BCDj" style="text-align: right" title="Exercisable">57,190</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025 July Private Placement - pre-funded warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_zLEGddaBiIwd" style="text-align: right" title="Warrants">56,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_90B_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_z1iLjONMgx81" title="Warrant Term">Until exercised in full</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_zErp2orMp8f2" style="text-align: right" title="Warrants">0.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_z18IdeVWWwcg" style="text-align: right" title="Exercisable">56,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025 July Private Placement – common warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zexv9mafowEi" style="text-align: right" title="Warrants">848,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_90A_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zDULMYc9Dhj9" title="Warrant Term">January 2031</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zn6HD0pUByGd" style="text-align: right" title="Warrants">4.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zdsEnkN3SNvk" style="text-align: right" title="Exercisable">848,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026 Private Placement - common warrants (note 10.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_z8yl1sWTo6G4" style="text-align: right" title="Warrants">374,857</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_90F_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_zc4Z7nB8hu88" title="Warrant Term">March 2031</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_zbrvWdC5PRy7" style="text-align: right" title="Warrants">2.625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_zPoIQ5SDiRbb" style="text-align: right" title="Exercisable">374,857</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Quantum Israel Acquisition - pre-funded warrants (note 10.E)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember_zRzkNDQf9mI4" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants">2,009,507</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: right; padding-bottom: 1pt">Until exercised in full</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember_zgzafpu72luf" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants">0.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember_znouqYzsDPPl" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable">2,009,507</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260630_zCoZs9xUgzI7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding as of January 1, 2025">6,202,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: right; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260630_zzpvMKOw9AGa" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding as of June 30, 2025">6,202,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table summarizes the activity in outstanding warrants during the six months ended June 30, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants outstanding as of January 1, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants granted</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants Exercised</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants outstanding as of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Class J Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zZmFqfr9qS8l" style="width: 12%; text-align: right" title="Warrants outstanding beginning">32,584</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zPjjpSu6fHYc" style="width: 12%; text-align: right" title="Warrants granted">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zhlZyzrdvGPh" style="width: 12%; text-align: right" title="Warrants exercised">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z6QNNsK1fpPh" style="width: 12%; text-align: right" title="Warrants outstanding ending">32,584</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class K Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zaoBDM00U2La" style="text-align: right" title="Warrants outstanding beginning">32,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zyjN8e8DPhri" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zIyQzAt84pZ7" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zhSXXU9qAhde" style="text-align: right" title="Warrants outstanding ending">32,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">June 2024 Facility Agreement Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zCLUbxlb9Raf" style="text-align: right" title="Warrants outstanding beginning">174,141</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zbXj3gl4Pw86" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z5ymCQjgmptc" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zTLLTUoIVpwe" style="text-align: right" title="Warrants outstanding ending">174,141</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">June 2024 Lead Lender Fee Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zhbJRY1YCQu2" style="text-align: right" title="Warrants outstanding beginning">5,296,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zIyWIfSi6Ff1" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zQdxOykJn4jb" style="text-align: right" title="Warrants exercised">(2,680,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zbN47NxBIhf4" style="text-align: right" title="Warrants outstanding ending">2,616,610</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024 PIPE Warrants (note 10.B)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z20XKzIWU4ke" style="text-align: right" title="Warrants outstanding beginning">57,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zPcMexfgeZ68" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zOECou742Cq" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zBVyHaDTGWhd" style="text-align: right" title="Warrants outstanding ending">57,190</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025 July Private Placement - pre-funded warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z6p6mFLNO4vl" style="text-align: right" title="Warrants outstanding beginning">56,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z3iidkRIEiWd" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zX8mjropJoEh" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_znjfNwF9ynMa" style="text-align: right" title="Warrants outstanding ending">56,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025 July Private Placement – common warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zDgrGp4C4qwd" style="text-align: right" title="Warrants outstanding beginning">925,923</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zUWWPjCLNAWd" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zHwY9QjIfA58" style="text-align: right" title="Warrants exercised">(77,576</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zlLJbpi4Kc6h" style="text-align: right" title="Warrants outstanding ending">848,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026 Private Placement - common warrants (note 10.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zf85bB2ygMQd" style="text-align: right" title="Warrants outstanding beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zn9qN47w8roj" style="text-align: right" title="Warrants granted">672,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z5HL2Jibouhj" style="text-align: right" title="Warrants exercised">(297,143</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zXD7Q9yzKaZj" style="text-align: right" title="Warrants outstanding ending">374,857</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Quantum Israel Acquisition - pre-funded warrants (note 10.E)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zCHgLjVfLtqb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding beginning">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zRV08jsclmi2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants granted">4,447,595</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zXxiNA6N1fn7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised">(2,438,088</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z7zu8SMinUU9" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding ending">2,009,507</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zusottWdGDXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding beginning">6,575,616</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zUXcf58M6lKc" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants granted">5,119,595</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zwI77ooiu4yg" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercised">(5,492,807</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zdm7NKxQ6l6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding ending">6,202,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> G. Reverse Stock Split: On July 15, 2024, the Company filed an amendment to its Amended COI to effect a 1-for-4 reverse stock split of the Company’s Common Stock (the “Reverse Stock Split”). The Reverse Stock Split became effective on March 14, 2025. As a result of the Reverse Stock Split, every 4 outstanding shares of the Company’s common stock were converted into 1 share of the Company’s common stock. The Reverse Stock Split did not change the par value of the Company’s common stock or the number of its authorized shares. Share and per share data in these financial statements have been retrospectively adjusted to reflect the Reverse Stock Split for periods presented prior to the Reverse Stock Split. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 10: SHAREHOLDERS’ EQUITY (Cont.) H. Share option plan: On March 2, 2023, the Board approved the adoption of the 2023 Stock Incentive Plan (the “2023 Plan”). The 2023 Plan permits the issuance of up to (i) <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230302__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeStockIncentivePlanMember_zyzGcaLFD4F1" title="Shares granted">625,000 shares of Common Stock, plus (ii) an annual increase equal to the lesser of (A) <span id="xdx_906_ecustom--OutstandingCapitalStockPercent_iI_pid_dp_uPure_c20230302__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeStockIncentivePlanMember_z98NJwMfKi3b" title="Outstanding capital stock percent">5% of the Company’s outstanding capital stock on the last day of the immediately preceding calendar year; and (B) such smaller amount as determined by the Board, provided that no more than <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230302__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeStockIncentivePlanMember_zHdbeeKMlTxl" title=" Shares, granted">625,000 shares of Common Stock may be issued upon the exercise of Incentive Stock Options. If any outstanding awards expire, are canceled or are forfeited, the underlying shares would be available for future grants under the 2023 Plan. The 2023 Plan provides for the grant of stock options, restricted stock, restricted stock units, stock or other stock-based awards, under various tax regimes, including, without limitation, in compliance with Section 102 and Section 3(i) of the Israeli Income Tax Ordinance (New Version) 5271-1961, and for awards granted to United States employees or service providers, including those who are deemed to be residents of the United States for tax purposes, Section 422 and Section 409A of the United States Internal Revenue Code of 1986. In connection with the adoption of the 2023 Plan, on March 7, 2023, the Company entered into certain intercompany reimbursement agreements with two of its subsidiaries, Viewbix Israel and Gix Media (the “Recharge Agreements”). The Recharge Agreements provide for the offer of awards under the 2023 Plan to employees or service providers of Viewbix Israel and Gix Media (the “Affiliates”) under the 2023 Plan. Under the Recharge Agreements, the Affiliates will each bear the costs of awards granted to its employees or its service providers under the 2023 Plan and will reimburse the Company upon the issuance of shares of Common Stock pursuant to an award, for the costs of shares issued, but in any event not prior to the vesting of an award. The reimbursement amount will be equal to the lower of (a) the book expense for such award as recorded on the financial statements of one of the respective Affiliates, determined and calculated according to U.S. GAAP, or any other financial reporting standard that may be applicable in the future, or (b) the fair value of the shares of Common Stock at the time of exercise of an option or at the time of vesting of an RSU, as applicable. On July 11, 2025, in accordance with the terms of the 2023 Plan, the Company’s board of directors approved an increase in the number of shares of common stock reserved for issuance under the 2023 Plan by up to <span id="xdx_90C_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20250711__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTAZGnnb0d3f" title="Common stock, capital shares reserved for future issuance">2,713,613 shares. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data)

1323000

0.1999 1

663000

662957

1.00

896636

722495

100000

1.00

650000

160000

1.00

520000

37500

75000

5296610

2680000

1265000

256875

1.00

385332

1.00

P3Y

10000

13000

12844

257000

385332

328142

328000

848763

77160

925923

4.86

4.8599

0.0001

4.74

0.070

50000

4500000

477000

20576

77576

368000

800000

640000

1.75

2.625

P5Y

70000

32000

200000

800000

672000

1400000

70000

672000

297143

780000

1866000

4447595

0.0001

2438088

2438087

The following table summarizes information of outstanding warrants as of June 30, 2026: SCHEDULE OF OUTSTANDING WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Term</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 32%; text-align: left">Class J Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zk8sJ074APti" style="width: 12%; text-align: right" title="Warrants">32,584</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 18%; text-align: right">July 2029</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zAGLTDkBFE8f" style="width: 12%; text-align: right" title="Warrants">53.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zBAN1F3rQi97" style="width: 12%; text-align: right" title="Exercisable">32,584</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class K Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zIW5EftzflI5" style="text-align: right" title="Warrants">32,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right">July 2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxKm1NXv9T1l" style="text-align: right" title="Warrants">89.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zlucH2amA6Gk" style="text-align: right" title="Exercisable">32,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">June 2024 Facility Agreement Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_zEm9jkQRhST8" style="text-align: right" title="Warrants">174,141</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_900_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_zYsueRkduIA2" title="Warrant Term">June 2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_znLEksYNwHya" style="text-align: right" title="Warrants">1.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember_zOwrQYdLOZxd" style="text-align: right" title="Exercisable">174,141</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">June 2024 Lead Lender Fee Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_z2EOF6QIsBHg" style="text-align: right" title="Warrants">2,616,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right">June 2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_z5mVtVnGfoBe" style="text-align: right" title="Warrants">0.472</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember_zILdP09WdsVl" style="text-align: right" title="Exercisable">2,616,610</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024 PIPE Warrants (note 10.B)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember_zbXhCFtuCIO4" style="text-align: right" title="Warrants">57,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right">July 2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember_zaEDC6Cix4i2" style="text-align: right" title="Warrants">1.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember_zwJBckp8BCDj" style="text-align: right" title="Exercisable">57,190</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025 July Private Placement - pre-funded warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_zLEGddaBiIwd" style="text-align: right" title="Warrants">56,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_90B_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_z1iLjONMgx81" title="Warrant Term">Until exercised in full</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_zErp2orMp8f2" style="text-align: right" title="Warrants">0.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember_z18IdeVWWwcg" style="text-align: right" title="Exercisable">56,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025 July Private Placement – common warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zexv9mafowEi" style="text-align: right" title="Warrants">848,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_90A_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zDULMYc9Dhj9" title="Warrant Term">January 2031</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zn6HD0pUByGd" style="text-align: right" title="Warrants">4.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember_zdsEnkN3SNvk" style="text-align: right" title="Exercisable">848,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026 Private Placement - common warrants (note 10.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_z8yl1sWTo6G4" style="text-align: right" title="Warrants">374,857</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_90F_ecustom--WarrantsOutstandingTerm_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_zc4Z7nB8hu88" title="Warrant Term">March 2031</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_zbrvWdC5PRy7" style="text-align: right" title="Warrants">2.625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember_zPoIQ5SDiRbb" style="text-align: right" title="Exercisable">374,857</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Quantum Israel Acquisition - pre-funded warrants (note 10.E)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember_zRzkNDQf9mI4" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants">2,009,507</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: right; padding-bottom: 1pt">Until exercised in full</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember_zgzafpu72luf" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants">0.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember_znouqYzsDPPl" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable">2,009,507</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260630_zCoZs9xUgzI7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding as of January 1, 2025">6,202,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: right; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260630_zzpvMKOw9AGa" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding as of June 30, 2025">6,202,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table summarizes the activity in outstanding warrants during the six months ended June 30, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants outstanding as of January 1, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants granted</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants Exercised</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants outstanding as of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Class J Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zZmFqfr9qS8l" style="width: 12%; text-align: right" title="Warrants outstanding beginning">32,584</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zPjjpSu6fHYc" style="width: 12%; text-align: right" title="Warrants granted">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zhlZyzrdvGPh" style="width: 12%; text-align: right" title="Warrants exercised">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z6QNNsK1fpPh" style="width: 12%; text-align: right" title="Warrants outstanding ending">32,584</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class K Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zaoBDM00U2La" style="text-align: right" title="Warrants outstanding beginning">32,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zyjN8e8DPhri" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zIyQzAt84pZ7" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zhSXXU9qAhde" style="text-align: right" title="Warrants outstanding ending">32,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">June 2024 Facility Agreement Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zCLUbxlb9Raf" style="text-align: right" title="Warrants outstanding beginning">174,141</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zbXj3gl4Pw86" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z5ymCQjgmptc" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwoThousandTwentyFourFacilityAgreementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zTLLTUoIVpwe" style="text-align: right" title="Warrants outstanding ending">174,141</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">June 2024 Lead Lender Fee Warrants (note 7.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zhbJRY1YCQu2" style="text-align: right" title="Warrants outstanding beginning">5,296,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zIyWIfSi6Ff1" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zQdxOykJn4jb" style="text-align: right" title="Warrants exercised">(2,680,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentyTwentyFourLeadLenderWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zbN47NxBIhf4" style="text-align: right" title="Warrants outstanding ending">2,616,610</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024 PIPE Warrants (note 10.B)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z20XKzIWU4ke" style="text-align: right" title="Warrants outstanding beginning">57,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zPcMexfgeZ68" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zOECou742Cq" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFourPIPEWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zBVyHaDTGWhd" style="text-align: right" title="Warrants outstanding ending">57,190</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025 July Private Placement - pre-funded warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z6p6mFLNO4vl" style="text-align: right" title="Warrants outstanding beginning">56,584</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z3iidkRIEiWd" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zX8mjropJoEh" style="text-align: right" title="Warrants exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementPrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_znjfNwF9ynMa" style="text-align: right" title="Warrants outstanding ending">56,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025 July Private Placement – common warrants (note 10.C)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zDgrGp4C4qwd" style="text-align: right" title="Warrants outstanding beginning">925,923</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zUWWPjCLNAWd" style="text-align: right" title="Warrants granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zHwY9QjIfA58" style="text-align: right" title="Warrants exercised">(77,576</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentyFiveJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zlLJbpi4Kc6h" style="text-align: right" title="Warrants outstanding ending">848,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026 Private Placement - common warrants (note 10.D)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zf85bB2ygMQd" style="text-align: right" title="Warrants outstanding beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zn9qN47w8roj" style="text-align: right" title="Warrants granted">672,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z5HL2Jibouhj" style="text-align: right" title="Warrants exercised">(297,143</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--TwentyTwentySixJulyPrivatePlacementCommonWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zXD7Q9yzKaZj" style="text-align: right" title="Warrants outstanding ending">374,857</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Quantum Israel Acquisition - pre-funded warrants (note 10.E)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zCHgLjVfLtqb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding beginning">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zRV08jsclmi2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants granted">4,447,595</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zXxiNA6N1fn7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised">(2,438,088</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--QuantumIsraelAcquisitionPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_z7zu8SMinUU9" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding ending">2,009,507</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zusottWdGDXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding beginning">6,575,616</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_ecustom--WarrantGrantedShares_pid_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zUXcf58M6lKc" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants granted">5,119,595</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_ecustom--WarrantExercisesShares_iN_pid_di_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zwI77ooiu4yg" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercised">(5,492,807</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--WarrantMember_zdm7NKxQ6l6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding ending">6,202,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

32584

July 2029

53.76

32584

July 2029

89.60

32584

174141

June 2027

1.00

174141

2616610

June 2027

0.472

2616610

57190

July 2027

1.00

57190

56584

Until exercised in full

0.00

56584

848347

January 2031

4.74

848347

374857

March 2031

2.625

374857

2009507

Until exercised in full

0.00

2009507

6202404

32584

174141

5296610

2680000

2616610

57190

56584

925923

77576

848347

672000 297143

374857

4447595 2438088

2009507

6575616

5119595 5492807

6202404

1-for-4

every 4 outstanding shares of the Company’s common stock were converted into 1 share of the Company’s common stock.

625000

0.05

625000

2713613

NOTE 11: EARNING (LOSS) PER SHARE Basic net earnings (loss) per share is computed by dividing net earnings (loss) attributable to ordinary shareholders of Quantum X Labs Inc. by the weighted average number of shares of common stock outstanding for the reporting periods. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) attributable to ordinary shareholders of Quantum X Labs Inc including adjustment of the interest expenses on the Company’s convertible loans, by the weighted-average number of shares of common stock and the potential dilutive common shares outstanding during the period. Diluted shares outstanding include the dilutive effect of in-the-money warrants using the treasury stock method and the potential conversion of the Company’s convertible loans into shares. For the six and three months ended June 30, 2025, the Company reported a net loss, therefore did not take into account dilutive effect. As a result, the basic net loss per share was equal to the dilutive net loss per share. The following table presents the numerator and denominator of the basic and diluted net loss per share computations: SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260101__20260630_zq72Jco2TUk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250630_zDU0mKoSVH25" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260401__20260630_z0yzzhFxj1J" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250401__20250630_zDjqztZrpozk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator for basic earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_zX0xo3fzZpC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Net income (loss) attributable to Quantum X Labs Inc shareholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">1,880</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">(15,326</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">2,485</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">(11,658</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockDividendsAndOtherAdjustments_pn3n3_zGLC8BCuBlL9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest expenses on convertible loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator for diluted earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_z7lcet7CyIVb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Adjusted net income (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,923</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(15,326</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,658</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Denominator for basic earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_z6QUGQts8ke4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,903,662</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,330,104</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,292,085</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,235,599</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_zoJ9FSKISoE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants and converted loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,140,200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,782,540</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_z9r4wpgxeiNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dilutive potential common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,140,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,782,540</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Denominator for diluted earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zYoLWaT5FdT1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Adjusted weighted average shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">19,043,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,330,104</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">20,074,625</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,235,599</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareBasic_pid_zR15r6Xczcw8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic earnings (loss) per share attributable to Quantum X Labs Inc shareholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.42</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.61</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareDiluted_pid_z0YrKPRQV8Ue" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Diluted earnings (loss) per share attributable to Quantum X Labs Inc shareholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.42</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.61</td><td style="text-align: left">)</td></tr> </table> QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data)

The following table presents the numerator and denominator of the basic and diluted net loss per share computations: SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260101__20260630_zq72Jco2TUk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250630_zDU0mKoSVH25" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260401__20260630_z0yzzhFxj1J" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250401__20250630_zDjqztZrpozk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator for basic earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_zX0xo3fzZpC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Net income (loss) attributable to Quantum X Labs Inc shareholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">1,880</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">(15,326</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">2,485</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">(11,658</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockDividendsAndOtherAdjustments_pn3n3_zGLC8BCuBlL9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest expenses on convertible loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator for diluted earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_z7lcet7CyIVb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Adjusted net income (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,923</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(15,326</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,658</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Denominator for basic earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_z6QUGQts8ke4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,903,662</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,330,104</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,292,085</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,235,599</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_zoJ9FSKISoE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants and converted loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,140,200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,782,540</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_z9r4wpgxeiNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dilutive potential common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,140,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,782,540</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Denominator for diluted earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zYoLWaT5FdT1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Adjusted weighted average shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">19,043,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,330,104</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">20,074,625</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,235,599</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareBasic_pid_zR15r6Xczcw8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic earnings (loss) per share attributable to Quantum X Labs Inc shareholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.42</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.61</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareDiluted_pid_z0YrKPRQV8Ue" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Diluted earnings (loss) per share attributable to Quantum X Labs Inc shareholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.42</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.61</td><td style="text-align: left">)</td></tr> </table>

1880000

-15326000

2485000

-11658000

43000

17000

1923000

-15326000

2502000

-11658000

12903662

6330104

14292085

7235599

6140200000

5782540000

6140200

5782540

19043862

6330104

20074625

7235599

0.15

-2.42

0.17

-1.61

0.10

-2.42

0.12

-1.61

NOTE 12: SEGMENT REPORTING The Group operates in such a way that each company in the Group represents a one separate business segment. These business segments currently do not include Metagramm’s operations as they do not meet the segment definition criteria. Search segment - the search segment develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of obtaining and routing internet user traffic to its customers. The search segment activity is conducted by Gix Media. Digital content segment - the digital content segment was engaged in the creation and editing of content, in different languages, for different target audiences, for the purposes of generating revenues from leading advertising platforms, including Google, Facebook, Yahoo and Apple, by utilizing such content to obtain internet user traffic for its customers. The digital content segment activity was conducted by Cortex until November 9, 2025 (see note 6.A), after which the Group ceased operations in this segment and continued to operate solely in the search segment (see note 3). Quantum technology segment – the quantum technology segment generally comprises three principal areas: quantum computing, quantum communication, and quantum sensing. Quantum computing applies principles of quantum mechanics to perform certain computational tasks more efficiently than classical systems and to address problems that are not practically solvable using conventional computing. Quantum communication focuses on the transmission of information using quantum methods and is designed to enhance the security of data exchange. Quantum sensing involves the use of quantum-based systems to measure physical phenomena, such as electromagnetic fields, gravity, and time, with significantly greater sensitivity than traditional sensors. The quantum technology segment activity is conducted by Quantum Israel. The segments’ results include items that directly serve and/or are used by the segment’s business activity and are directly allocated to the segment. As such they do not include depreciation and amortization expenses for intangible assets created at the time of the purchase of those companies and financing expenses incurred on loans taken for the purpose of purchasing those companies. Therefore, these items are not allocated to the various segments. The chief executive officer, who is the Company’s chief operating decision maker (“CODM”), assesses performance for these segments and decides how to allocate resources based the segments’ operating income or loss and income or loss before tax. Segments’ assets and liabilities are not reviewed by the CODM and therefore were not reflected in the segment reporting. The significant expense categories comprising segments profit and loss regularly reviewed by the CODM for the periods ended June 30, 2026 and 2025 are set forth in the table below. QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 12: SEGMENT REPORTING (Cont.) A substantial portion of non-current assets is derived from Israel and a substantial portion of revenues is derived from the United States. Segments revenues and operating results: SCHEDULE OF SEGMENTS REVENUES AND OPERATING RESULTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zjaF7jRnjQYe" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_zycgvzeSrW27" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zPOVdA8cufO6" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260101__20260630_zpKGOAEpMU21" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_pn3n3_zYJo0R3wof82" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">626</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">20</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">646</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_zwVglRKZQiPk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Traffic-acquisition and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ResearchAndDevelopmentExpenses_pn3n3_zOdLJ2NkQk8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--SellingAndMarketingExpenses_pn3n3_zJZBmLUPZnM" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--GeneralAndAdministrativeExpenses_pn3n3_ziZe6NLGUr48" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">981</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DepreciationAndAmortizationExpenses_pn3n3_z7mBq3mGqSZ7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">452</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">452</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_znkuuO8SVzxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">122</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_pn3n3_z6HFwfgZKkxf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(579</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,452</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,945</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_zotYlItfPR8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain from deconsolidation of a subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Financial expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_z0AjLGbcT768" style="text-align: right" title="Financial expenses, net">(81</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_z5wCDbbhV1H9" style="text-align: right" title="Financial expenses, net">25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zEOnS0WFXIj1" style="text-align: right" title="Financial expenses, net">(128</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630_z8kxvskaNK6h" style="text-align: right" title="Financial expenses, net">(184</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_zHzvQc36rWlh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(554</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,702</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zDWnQeUd6jfb" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm0M5TqKQrXe" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20250101__20250630_z5uXEHn8YW65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_pn3n3_zKylROUjLRm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">883</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">16</td><td style="width: 3%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">899</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_ze6d5Bh7jRcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Traffic-acquisition and related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ResearchAndDevelopmentExpenses_pn3n3_zHU8ErxwuUmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--SellingAndMarketingExpenses_pn3n3_z22cQ1cOjHE7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--GeneralAndAdministrativeExpenses_pn3n3_z7rpiRnP1Eq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">145</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">755</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DepreciationAndAmortizationExpenses_pn3n3_zc45UdHGyM34" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">408</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">408</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_zcSIXG9XHQ96" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">544</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">544</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_pn3n3_zcW8ICiV4UCj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,546</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,078</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial expenses, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zXTlhr1wE6Hb" style="text-align: right" title="Financial expenses, net">(40</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zdXx9jFycink" style="text-align: right" title="Financial expenses, net">(10,488</td><td style="text-align: left">)(*)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250101__20250630_zXTeWQMsghwj" style="text-align: right" title="Financial expenses, net">(10,528</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_z5az2I3G8VTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">428</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,034</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,606</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zINvzmzsg0Fg" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_zIxkRvR2wRC7" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5LiwhVib8pa" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20260401__20260630_z8917vncJDAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_pn3n3_z4gIGMIm3xyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">283</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">10</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">293</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_zvfiZDLTqDGa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Traffic-acquisition and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--ResearchAndDevelopmentExpenses_pn3n3_z1fdYrMsKFS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--SellingAndMarketingExpenses_pn3n3_z8AWttpQpiWg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--GeneralAndAdministrativeExpenses_pn3n3_zpzITgqW2Cg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,015</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DepreciationAndAmortizationExpenses_pn3n3_zshTXqxEjHCd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">228</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">228</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_zNtFEaH99oB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingIncomeLoss_pn3n3_zpg4raO4OZY4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(41</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(579</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(775</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,395</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_zZHqZrXIQYk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain from deconsolidation of a subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Financial expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zbN8aLVhZeH9" style="text-align: right" title="Financial expenses, net">(77</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_zL5Og6gxYXl" style="text-align: right" title="Financial expenses, net">25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zflDZPD9SKz6" style="text-align: right" title="Financial expenses, net">(61</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630_zORkBYMrzezd" style="text-align: right" title="Financial expenses, net">(113</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_z8jzeViNctHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(118</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(554</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,995</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,323</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zka7fjwC4lme" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zX1DpNsAHtFj" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20250401__20250630_zTAds3BNRDB4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_pn3n3_zM8G6XeE1zyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">354</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">16</td><td style="width: 3%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">370</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_zUKf90VSDEGd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Traffic-acquisition and related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ResearchAndDevelopmentExpenses_pn3n3_zZMSZ7k6WPie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--SellingAndMarketingExpenses_pn3n3_zwOGMA3b3eXc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--GeneralAndAdministrativeExpenses_pn3n3_zhSAhLidnoJ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">488</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">558</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DepreciationAndAmortizationExpenses_pn3n3_z7s6rgTEgO53" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_zxcB8sDl1rAc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_pn3n3_zAYXVaUFjxml" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,207</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,023</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial expenses, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zTObZfM0aXhf" style="text-align: right" title="Financial expenses, net">(35</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zECve7P7qpDa" style="text-align: right" title="Financial expenses, net">(7,626</td><td style="text-align: left">)(*)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250401__20250630_zYvqF28sunpb" style="text-align: right" title="Financial (expenses) income, net">(7,661</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_zStSD8ze1B27" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,833</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,684</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(*)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of financial expenses arising from changes in the fair value of financial assets measured at fair value through profit or loss (see note 8).</td></tr> </table> QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data) NOTE 12: SEGMENT REPORTING (Cont.) <p id="xdx_896_eus-gaap--ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_zXhU788Q3kOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The “adjustments and eliminations” column for segment operating income includes unallocated selling, general, and administrative expenses and certain items which management excludes from segment results when evaluating segment performance, as follows: SCHEDULE OF RECONCILIATION BETWEEN SEGMENTS OPERATING RESULTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Depreciation and amortization expenses not attributable to segments (**)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____ziBOTNby6Ki6" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(452</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____zMEPVtxi6NBc" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(408</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues, research and development expenses, sales and marketing expenses, general and administrative expenses and other expenses, net not attributable to the segments (***)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zLsaJNHg3l12" style="text-align: right" title="Goodwill Impairment">(1,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zUDulAY9e1v9" style="text-align: right" title="Goodwill Impairment">(1,138</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Gain from deconsolidation of a subsidiary</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zcgUiH0wieq8" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">3,831</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_z71J0B26kxei" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zQ6gOrQj2A4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">2,379</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zrpEaG9YxpId" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(1,546</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Depreciation and amortization expenses not attributable to segments (**)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____zWsTZISZJywa" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(228</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____zFAD3WIdsB49" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(235</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues, research and development expenses, sales and marketing expenses, general and administrative expenses and other expenses, net not attributable to the segments (***)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zOdXbnxQU4o4" style="text-align: right" title="Goodwill Impairment">(547</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zQgIG0IMPYg8" style="text-align: right" title="Goodwill Impairment">(972</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Gain from deconsolidation of a subsidiary</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zW71LmdaPbs8" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">3,831</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zia565MweMh5" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_pn3n3_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zJq245bfnyG5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,056</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingIncomeLoss_pn3n3_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zz6QLHLL4LZf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(1,207</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(*)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of financial expenses arising from changes in the fair value of financial assets measured at fair value through profit or loss (see note 8).</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(**) </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of technology and customer relations amortization costs from business combinations. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">(***)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of general and administrative expenses such as salaries and related expenses and professional services.</td></tr> </table> QUANTUM X LABS INC. (formerly known as Viewbix Inc.) NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) U.S. dollars in thousands (except share data)

Segments revenues and operating results: SCHEDULE OF SEGMENTS REVENUES AND OPERATING RESULTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zjaF7jRnjQYe" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_zycgvzeSrW27" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zPOVdA8cufO6" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260101__20260630_zpKGOAEpMU21" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_pn3n3_zYJo0R3wof82" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">626</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">20</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">646</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_zwVglRKZQiPk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Traffic-acquisition and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ResearchAndDevelopmentExpenses_pn3n3_zOdLJ2NkQk8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--SellingAndMarketingExpenses_pn3n3_zJZBmLUPZnM" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--GeneralAndAdministrativeExpenses_pn3n3_ziZe6NLGUr48" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">981</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DepreciationAndAmortizationExpenses_pn3n3_z7mBq3mGqSZ7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">452</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">452</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_znkuuO8SVzxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">122</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_pn3n3_z6HFwfgZKkxf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(579</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,452</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,945</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_zotYlItfPR8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain from deconsolidation of a subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Financial expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_z0AjLGbcT768" style="text-align: right" title="Financial expenses, net">(81</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_z5wCDbbhV1H9" style="text-align: right" title="Financial expenses, net">25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zEOnS0WFXIj1" style="text-align: right" title="Financial expenses, net">(128</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260101__20260630_z8kxvskaNK6h" style="text-align: right" title="Financial expenses, net">(184</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_zHzvQc36rWlh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(554</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,702</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zDWnQeUd6jfb" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm0M5TqKQrXe" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20250101__20250630_z5uXEHn8YW65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_pn3n3_zKylROUjLRm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">883</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">16</td><td style="width: 3%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">899</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_ze6d5Bh7jRcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Traffic-acquisition and related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ResearchAndDevelopmentExpenses_pn3n3_zHU8ErxwuUmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--SellingAndMarketingExpenses_pn3n3_z22cQ1cOjHE7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--GeneralAndAdministrativeExpenses_pn3n3_z7rpiRnP1Eq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">145</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">755</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DepreciationAndAmortizationExpenses_pn3n3_zc45UdHGyM34" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">408</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">408</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_zcSIXG9XHQ96" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">544</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">544</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_pn3n3_zcW8ICiV4UCj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,546</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,078</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial expenses, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zXTlhr1wE6Hb" style="text-align: right" title="Financial expenses, net">(40</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zdXx9jFycink" style="text-align: right" title="Financial expenses, net">(10,488</td><td style="text-align: left">)(*)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250101__20250630_zXTeWQMsghwj" style="text-align: right" title="Financial expenses, net">(10,528</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_z5az2I3G8VTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">428</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,034</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,606</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zINvzmzsg0Fg" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_zIxkRvR2wRC7" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5LiwhVib8pa" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20260401__20260630_z8917vncJDAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quantum technology segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_pn3n3_z4gIGMIm3xyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">283</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">10</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">293</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_zvfiZDLTqDGa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Traffic-acquisition and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--ResearchAndDevelopmentExpenses_pn3n3_z1fdYrMsKFS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--SellingAndMarketingExpenses_pn3n3_z8AWttpQpiWg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--GeneralAndAdministrativeExpenses_pn3n3_zpzITgqW2Cg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,015</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DepreciationAndAmortizationExpenses_pn3n3_zshTXqxEjHCd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">228</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">228</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_zNtFEaH99oB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingIncomeLoss_pn3n3_zpg4raO4OZY4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(41</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(579</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(775</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,395</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_zZHqZrXIQYk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain from deconsolidation of a subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,831</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Financial expenses (income), net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zbN8aLVhZeH9" style="text-align: right" title="Financial expenses, net">(77</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--QuantumTechnologySegmentMember_zL5Og6gxYXl" style="text-align: right" title="Financial expenses, net">25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zflDZPD9SKz6" style="text-align: right" title="Financial expenses, net">(61</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20260401__20260630_zORkBYMrzezd" style="text-align: right" title="Financial expenses, net">(113</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_z8jzeViNctHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(118</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(554</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,995</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,323</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zka7fjwC4lme" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_zX1DpNsAHtFj" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20250401__20250630_zTAds3BNRDB4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Search Segment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustments and eliminations (See below)</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_pn3n3_zM8G6XeE1zyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Revenues from external customers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">354</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">16</td><td style="width: 3%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">370</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationAcquisitionRelatedCost_pn3n3_zUKf90VSDEGd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Traffic-acquisition and related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ResearchAndDevelopmentExpenses_pn3n3_zZMSZ7k6WPie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--SellingAndMarketingExpenses_pn3n3_zwOGMA3b3eXc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--GeneralAndAdministrativeExpenses_pn3n3_zhSAhLidnoJ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">488</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">558</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DepreciationAndAmortizationExpenses_pn3n3_z7s6rgTEgO53" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherOperatingIncomeExpenseNet_iN_pn3n3_di_zxcB8sDl1rAc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expenses, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_pn3n3_zAYXVaUFjxml" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,207</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,023</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial expenses, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--SearchSegmentMember_zTObZfM0aXhf" style="text-align: right" title="Financial expenses, net">(35</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250401__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zECve7P7qpDa" style="text-align: right" title="Financial expenses, net">(7,626</td><td style="text-align: left">)(*)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--FinancialIncomeExpensesNet_pn3n3_di_c20250401__20250630_zYvqF28sunpb" style="text-align: right" title="Financial (expenses) income, net">(7,661</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_zStSD8ze1B27" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment income (loss), before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,833</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,684</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(*)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of financial expenses arising from changes in the fair value of financial assets measured at fair value through profit or loss (see note 8).</td></tr> </table>

626000

20000

646000

266000 266000 185000 185000 51000 51000 90000 444000 981000 1515000 452000 452000

-133000

50000

-39000

-122000

86000

-579000

-1452000

-1945000

3831000

81000 -25000 128000 184000

5000

-554000

2251000

1702000

883000

16000

899000

184000 184000 36000 36000 50000 50000 145000 610000 755000 408000 408000

-544000

468000

-1546000

-1078000

40000 10488000 10528000

428000

-12034000

-11606000

283000

10000

293000

134000 134000 185000 185000 26000 26000 37000 444000 534000 1015000 228000 228000

-127000

50000

-23000

-100000

-41000

-579000

-775000

-1395000

3831000

77000 -25000 61000 113000

-118000

-554000

2995000

2323000

354000

16000

370000

50000 50000 20000 20000 30000 30000 70000 488000 558000 235000 235000

-500000

184000

-1207000

-1023000

35000 7626000 7661000

149000

-8833000

-8684000

<p id="xdx_896_eus-gaap--ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_zXhU788Q3kOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The “adjustments and eliminations” column for segment operating income includes unallocated selling, general, and administrative expenses and certain items which management excludes from segment results when evaluating segment performance, as follows: SCHEDULE OF RECONCILIATION BETWEEN SEGMENTS OPERATING RESULTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Depreciation and amortization expenses not attributable to segments (**)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____ziBOTNby6Ki6" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(452</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____zMEPVtxi6NBc" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(408</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues, research and development expenses, sales and marketing expenses, general and administrative expenses and other expenses, net not attributable to the segments (***)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zLsaJNHg3l12" style="text-align: right" title="Goodwill Impairment">(1,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zUDulAY9e1v9" style="text-align: right" title="Goodwill Impairment">(1,138</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Gain from deconsolidation of a subsidiary</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zcgUiH0wieq8" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">3,831</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_z71J0B26kxei" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20260101__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zQ6gOrQj2A4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">2,379</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20250101__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zrpEaG9YxpId" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(1,546</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89.5%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Depreciation and amortization expenses not attributable to segments (**)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____zWsTZISZJywa" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(228</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_iN_pn3n3_di_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKQ_____zFAD3WIdsB49" style="width: 16%; text-align: right" title="Depreciation and amortization expenses not attributable to segments">(235</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues, research and development expenses, sales and marketing expenses, general and administrative expenses and other expenses, net not attributable to the segments (***)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zOdXbnxQU4o4" style="text-align: right" title="Goodwill Impairment">(547</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--GoodwillAndIntangibleAssetImpairment_iN_pn3n3_di_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_fKCoqKik___zQgIG0IMPYg8" style="text-align: right" title="Goodwill Impairment">(972</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Gain from deconsolidation of a subsidiary</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zW71LmdaPbs8" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">3,831</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DeconsolidationGainOrLossAmount_pn3n3_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zia565MweMh5" style="border-bottom: Black 1pt solid; text-align: right" title="Gain from deconsolidation of a subsidiary">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_pn3n3_c20260401__20260630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zJq245bfnyG5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,056</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingIncomeLoss_pn3n3_c20250401__20250630__srt--ConsolidationItemsAxis__us-gaap--IntersegmentEliminationMember_zz6QLHLL4LZf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(1,207</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(*)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of financial expenses arising from changes in the fair value of financial assets measured at fair value through profit or loss (see note 8).</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(**) </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of technology and customer relations amortization costs from business combinations. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">(***)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mainly consist of general and administrative expenses such as salaries and related expenses and professional services.</td></tr> </table>

452000

408000

1000000

1138000

3831000

2379000

-1546000

228000

235000

547000

972000

3831000

3056000

-1207000

NOTE 13: SUBSEQUENT EVENTS The Company has evaluated subsequent events from June 30, 2026, through August 13, 2026, the date of issuance of these financial statements: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On July 8, 2026, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260708__20260708__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9uRcHNjcewd" title="Stock issued during period shares, issued for services">4,894 shares of common stock to a former consultant as settlement of amounts owed for services previously provided.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On July 9, 2026, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260709__20260709__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentySixPIPEWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPiLzA80zEt4" title="Warrants exercised">228,571 warrants of the 2026 PIPE Warrants (see note 10.D) were exercised into <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260709__20260709__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentySixPIPEWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrrUJ5lMokqf" title="Warrants exercised">228,571 shares of common stock. The Company received total proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20260709__20260709__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandTwentySixPIPEWarrantsMember_zFZMTWj6yW6f" title="Proceeds from exercise of the warrants">600 upon exercise of the warrants.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">C.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During July 2026, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260701__20260731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zq2JSdeblEs6" title="Warrants exercised">1,916,610 of the June 2024 Lead Lender Fee Warrants (see note 7.D) were exercised into <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260701__20260731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGyydLffBAMj" title="Warrants exercised">1,916,610 shares of common stock. The Company received total proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromWarrantExercises_pn3n3_c20260701__20260731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyTwentyFourLeadLenderFeeWarrantsMember_zbGmVF6L9RA3" title="Proceeds from exercise of the warrants">905 upon exercise of the warrants.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">D.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On July 29, 2026, $589 of the Total Credit Facility Amount (see note 7.D) was converted into units, which included <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20260729__20260729__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za2fJfv2SU7c" title="Common stock issued upon conversion">588,553 shares of common stock and the same amount of warrants, each warrant is exercisable into one share of common stock of the Company at an exercise price of $1.00 per share for a 3 three-year period from the issuance date of the warrants.</td></tr> </table>

4894

228571

600000

1916610

905000

589000

588553

1.00

P3Y

Share and per share data in these financial statements for periods preceding the Reverse Stock Split have been retrospectively adjusted to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 10.G). Represents an amount less than $1. Share and per share data in these financial statements for periods preceding the Reverse Stock Split have been retrospectively adjusted to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 10.G). As of June 30, 2025, the Company identified indicators of impairment of the digital content reporting unit. As a result, the Company performed an impairment test which included a quantitative analysis of the fair value of the reporting unit. The fair value was estimated using the income approach, which is based on the present value of the future cash flows attributable to the reporting unit. The Company compared the fair value of the reporting unit to its carrying amount. As the carrying amount exceeded the fair value, the Company recognized an impairment loss of $3,150 which was driven mainly due to the Cortex Adverse Effect (see note 1.E) and due to a decrease in the cash flow projections. Mainly consist of financial expenses arising from changes in the fair value of financial assets measured at fair value through profit or loss (see note 8). Mainly consist of technology and customer relations amortization costs from business combinations. Mainly consist of general and administrative expenses such as salaries and related expenses and professional services.